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ABSTRACT
This thesis encompasses experimental work performed at The Canberra Hospital in
collaboration with the Centre for Medical Radiation Physics, University of Wollongong,
in the field of high dose rate (HDR) brachytherapy. The purpose of this research was to
develop an accurate and reliable in vivo dosimetry program that could be used to measure
the dose delivered to organs at risk, such as the rectum and bladder, during HDR
gynaecological brachytherapy. The current method of determining dose to these organs
is based on calculation of a point dose by the treatment planning system (TPS). This
calculation is limited in accuracy due to the inability of the TPS to consider
heterogeneities in the dose calculation process. The implementation of an alternate
dosimetry system independent to the TPS would be a useful tool for brachytherapy.
The instruments chosen for measuring dose were a PTW five-diode array for use in the
rectum; a PTW single diode probe for the bladder; and a uniquely designed Metal Oxide
Semiconductor Field Effect Transistor (MOSFET), known as a MOSkinTM, developed at
the Centre for Medical Radiation Physics. Diodes and MOSFETs are commonly used in
radiotherapy because of their desirable characteristics for accurate dose measurement. A
thimble ionisation chamber traceable to a primary standards laboratory was used as a
reference dosimeter for the calibration of these devices.
To develop a better understanding of how these dosimeters may respond when used in
brachytherapy, simulations were carried out using the EGSnrc Monte Carlo code. An
192

Ir source was modelled to emulate the microSelectron ‘Classic’ HDR brachytherapy

source used at The Canberra Hospital. The dose distribution and spectrum for this source
was analysed in various media to determine how these characteristics changed with
distance from the source. The Monte Carlo simulations showed a significant change in
the 192Ir photon spectrum with distance in water. The change in spectrum was attributed
to the increasing portion of low energy scattered photons with distance from the source.
Further investigation was also performed to determine the difference in dose deposited in
a small silicon voxel compared to a voxel of water at various distances from the source.

xxi

This gave an indication as to how the higher atomic number of the semiconductor
detectors would affect their response at lower photon energies. The implications of these
effects, i.e. the increase cross section for photoelectric absorption in silicon at low photon
energies, helped determine the most appropriate distance to calibrate the dosimeters.
After completing the Monte Carlo simulations, the inherent characteristics of the rectum
diode probe, bladder diode probe, and MOSkinTM were investigated. The characteristics
measured for each dosimeter included the energy dependence, angular dependence,
linearity, long-term and short-term reproducibility and temperature dependence.

By

determining the inherent characteristics of each device, an uncertainty in measurement
was calculated for each dosimeter.

It was also found that the ionisation chamber

displayed a poor spatial resolution when attempting to measure at distances close to the
source. This was attributed to the significant dose gradient across the large air volume of
the chamber. As a result, the ionisation chamber was deemed to be insufficient for
calibrating the dosimeters close to the source.
The final outcome of this work was the development of an appropriate calibration
procedure for the diode probes and MOSkinTM that was sufficiently accurate and easy to
reproduce.

Two different phantom designs were evaluated: the first being a fixed

cylindrical jig comprised of PMMA that could simultaneously calibrate all three
dosimeters against an ionisation chamber at 8 cm from the source; and the second a
perspex slab phantom allowing the dosimeters to be placed individually at any distance
between 2.3 and 8 cm from the source. Each phantom was imaged on a CT scanner and
reconstructed in the TPS so that the doses measured by each of the dosimeters could be
compared with those calculated by the TPS.

Under full scattering conditions the

dosimeters displayed good agreement with the TPS at large distances from the source but
as the dosimeters were moved closer to the source a discrepancy between measured and
calculated dose was observed. While calibrating at a non-clinically relevant depth of
8 cm was undesirable, the accuracy was far greater than attempting to calibrate the
dosimeters close to the source where a large dose gradient turns small errors in
positioning into significant errors in dose.
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Chapter 1:
Introduction
1.1

Brachytherapy

Brachytherapy is a radiation therapy treatment modality commonly used for the treatment
of cancer. The term ‘brachy’ implies short distance treatment as opposed to external
beam radiation therapy (EBRT), or teletherapy, where treatment is delivered from a
distance. Brachytherapy makes use of small radioactive sources that can be placed into
or immediately adjacent to the tissue to be treated, allowing a high dose to be delivered to
the tumour. The intensity of the source decreases according to the inverse square law
resulting in a rapid dose fall-off at short distances from the source. The significance of
this rapid dose fall-off in brachytherapy is that a highly localised dose can be delivered
directly to the tumour, while the surrounding normal tissue receives only a small fraction
of the total dose. For this reason, brachytherapy allows higher doses per fraction to be
delivered to the tumour, compared to the standard 2 Gray (Gy) per fraction used in
EBRT.

1.1.1 Brachytherapy Techniques
The practice of brachytherapy first began following the discovery of radium by Marie
Curie in 1898, where patients were treated using small quantities of radium placed on or
implanted into tumours (Godden 1988). Brachytherapy has evolved over the years with
the introduction of a variety of new radionuclides for brachytherapy, the use of remote
afterloading units, and the development of computer based dose calculation systems.
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The two main brachytherapy implant techniques used in modern-day treatment are:
Intracavity - in which the sources are placed in body cavities close to the tumour volume.
This method is mostly used for cancers of the uterine cervix, uterine body
and vagina; and
Interstitial - in which the sources are implanted directly into the tumour volume and the
surrounding tissue to be treated. Radioactive sources are fabricated in the
form of needles, wires, or seeds that can be inserted into the tissue. In the
case of remote afterloading brachytherapy, the source travels into the
treatment volume through the implanted needles, which are connected to the
afterloading unit.
Intracavity inserts are always temporary and usually of short duration, while interstitial
implants can be either temporary or permanent. The duration of the implant is dependent
on the prescribed dose and the dose rate delivered by the source employed for treatment.

1.1.2 Dose and Dose Rate in Brachytherapy
As previously mentioned, higher doses per fraction are often prescribed in brachytherapy
when compared to the conventional 2 Gy per fraction dose regimens used in EBRT. This
is predominantly a result of the rapid dose fall-off associated with brachytherapy sources,
but is also related to the rate at which the dose is delivered. Report 38 published by
International Commission on Radiation Units (ICRU 1985) classifies brachytherapy
treatment into three dose rate categories: low dose rate (LDR); medium dose rate (MDR);
and high dose rate (HDR). These dose rate classifications are displayed in Table 1.1.
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Table 1.1

Dose rate classifications as outlined in ICRU 38 for LDR, MDR and HDR
brachytherapy

treatments.

Table

is

taken

from

(Podgorsak

2005).

In the case of a permanent implant, dose is delivered continuously over the entire lifetime
of the source, or in other words, until the radioactive material has completely decayed.
The most common form of permanent implant these days are low dose rate (LDR) 125I or
103

Pd seeds used for prostate cancer brachytherapy treatments. The total dose delivered

over the radioactive lifetime of these seeds can be as much as 160 Gy. In contrary, the
dose for a temporary implant is usually delivered over a short period of time until the
prescribed dose has been reached. Temporary implants are often performed using high
dose rate (HDR) sources that have a very high activity and can deliver dose rates in
excess of 12 Gy per hour.

Modern HDR brachytherapy sources used in remote

afterloading units typically deliver dose rates between 100 and 300 Gy per hour
(Thomadsen, Rivard & Butler 2005). In the case of HDR gynaecological brachytherapy,
a dose of 18 Gy in 3 fractions (i.e. 6 Gy per fraction) is delivered with HDR
brachytherapy in addition to a dose of 50 Gy in 25 fractions delivered with EBRT. The
HDR brachytherapy component in this instance is usually carried out in the middle or at
the end of EBRT treatment.
Variations in dose fractionation schemes for HDR brachytherapy are common and often
depend on the referring clinician as well as the institution’s own procedures and
experience. With all forms of brachytherapy, the treatment technique, total prescribed
dose, and fractionation scheme depend on numerous parameters including: dose rate;
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radionuclide used; treatment site; type of implant (temporary or permanent); whether
brachytherapy is implemented as a monotherapy treatment or in conjunction with EBRT;
prior dose delivered with EBRT; patient suitability for the treatment; patient comfort; and
department resources. In addition, radiobiology outcomes are also of great importance
with indicators such as biological equivalent dose (BED) and early and late tissue effects,
all of which affect the prescribed course of treatment and the extent of the brachytherapy
treatment component. Radiobiological studies of the interaction of radiation with tumour
and normal tissue cells, as well as the effectiveness of radiation to kill cells, shows a
significant difference in the outcomes of HDR and LDR treatments for the same nominal
dose. As a result, models to equate different dose rate and fractionation regimens have
been developed, allowing comparison of two contrasting dose and dose rate delivery
techniques by the biologically effective dose (BED) parameter. A full description of this
radiobiological parameter and its use is beyond the relevant theory required for this work
but can be found in radiobiology textbooks such as Steel (2002).

1.1.3 High Dose Rate Gynaecological Brachytherapy
The focus of this study is HDR gynaecological brachytherapy based on temporary
intracavity implants.

Modern HDR gynaecological brachytherapy involves a single

radioactive source being driven into one or multiple applicators that have been inserted
into the patient’s cervix or vagina. The movement of the source in and out of the
applicators is controlled by a remote afterloading unit. The source is stepped through
each applicator for a set duration calculated by the treatment planning system (TPS) to
provide a dose distribution tailored to cover the intended treatment region. While a high
radiation dose is delivered locally to the tumour region, the organs in the immediate
vicinity of the cervix and vagina also receive a significant dose despite the rapid dose
fall-off with distance from the source. In gynaecological brachytherapy the organs at risk
are the bladder and rectum that lie in close proximity to the implanted applicator,
sometimes within a few centimetres. The TPS is often used to calculate the dose that the
rectum and bladder are expected to receive during the treatment. However, there are well
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known limitations with the TPS method of calculation which is described in further detail
throughout the thesis.

1.2

Dosimetry in High Dose Rate Brachytherapy

Dosimetry is a branch of medical physics concerned with the estimation of absorbed dose
by means of experimental or fundamental theoretical techniques (Thomadsen et al. 2005).
Experimental dosimetry consists of a detector, known as a dosimeter, which can produce
a measurable signal that has a known relationship to absorbed dose at a specified point in
the medium in the absence of the dosimeter. Direct measurement of dose distributions
around brachytherapy sources is difficult with any dosimeter due predominantly to the
large dose gradients, range of dose rates with distance from the source, and relatively low
photon energies.

A suitable dosimeter should be of small size, have a flat energy

response, high spatial resolution, good stability, and a uniform response with irradiation
time, temperature and angular orientation.

1.2.1 In vivo Dosimetry for High Dose Rate Brachytherapy
In vivo dosimetry is an effective way of measuring the dose delivered to the organs at risk
during HDR brachytherapy treatment. With the choice of an appropriate dosimeter, the
accumulative dose to the rectum or bladder can be measured in real-time. This provides
the radiation oncologist with an independent measurement of organ dose that can be
compared against the TPS. The other added benefit of in vivo dosimetry is that it can be
used as a tool to detect any gross errors; an example of such is an incorrect dose
calculation from the TPS due to an erroneous translation of dose prescription data. If
warranted, the treatment may be terminated based on the in vivo measurement to prevent
excessive dose being delivered to the rectum or bladder. Not all dosimeters can provide
the high spatial resolution required for brachytherapy, nor are all dosimeters capable of
measuring dose in real-time. The detectors proposed for in vivo dosimetry in this study
are a PTW diode array probe for measurement of rectum dose, a PTW single diode probe
for bladder dose, and a MOSkinTM MOSFET developed at the Centre for Medical
Radiation Physics (CMRP) capable of measuring dose in either the rectum or bladder.
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All three of these dosimeters possess the desirable characteristics mentioned earlier and
have been designed specifically for dose measurement in HDR brachytherapy.

1.3

Thesis Aims

The aim of the thesis is to develop and implement an in vivo dosimetry system for realtime measurement of the dose delivered to the organs at risk, that being the rectum and
bladder, during HDR gynaecological brachytherapy.

Included in this work is an

investigation into the characteristics of two diode probes and a metal oxide
semiconductor field effect transistor (MOSFET) to determine whether they are suitable
for this task.

Lastly, the development of an efficient and reproducible method for

calibrating the system is assessed in terms of accuracy and reliability that can then be
implemented as part of quality control for clinical treatment.

1.4

Overview of Thesis

The format of the thesis is intended to present a logical progression of the research
performed over the duration of the project.

The chapters include an introduction,

literature review and conclusion with three chapters in-between encompassing the
original research performed at The Canberra Hospital and University of Wollongong.
Chapter 1 provides an introductory background into brachytherapy, with a particular
focus on high dose rate gynaecological brachytherapy, as well as dosimetry and the
rationale for in vivo dosimetry in gynaecological procedures. It also states the aims of the
project and the intended outcomes of the research.
Chapter 2 contains a review of the literature relevant to this work. It includes a look at
brachytherapy for gynaecological cancer, systems for dose prescription and calculation,
treatment planning systems,

192

Ir sources, Monte Carlo simulation, and the principles of

in vivo dosimetry with a particular focus on the use of diodes and MOSFETs.
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Chapters 3, 4 and 5 contain the original contribution to this research including all the
data, results and analysis of the simulations and measurements performed over the course
of the project. Chapter 3 describes the Monte Carlo modelling of a microSelectron
‘Classic’

192

Ir HDR brachytherapy source to emulate the real source used in the

experimental methods in Chapters 4 and 5. The EGSnrc Monte Carlo platform was
employed to simulate depth dose data and spectral data along the central axis of the
source using the DOSRZnrc and FLURZnrc codes respectively. The Monte Carlo data
was used to gain an understanding into how dose is distributed around the source and
determine the photon energies present at the depths intended to be used during the
measurements. This information, as well as further simulations used to determine the
difference in dose deposited in silicon compared to water, provided insight as to how the
diode probes and MOSkinTM would respond when it came to performing physical
measurements.
Chapter 4 describes the characterisation of each dosimeter for measuring dose in the
vicinity of an

192

Ir HDR brachytherapy source. The performance of the rectum diode

array, bladder diode probe and MOSkinTM were all evaluated in terms of their energy
response, angular dependence, linearity, temperature response, and short- and long-term
reproducibility. In addition, a 0.6 cc Farmer ionisation chamber’s ability to measure dose
at various distances from the source is evaluated for the purpose of calibrating the
dosimeters. By determining the characteristics of each dosimeter and assessing the
uncertainty involved in measurement, an overall uncertainty is calculated for each device.
Chapter 5 presents an investigation into the best method to calibrate the diode probes and
MOSkinTM based on the findings of the previous chapter. The aim of the chapter is to
develop a method that is simple, accurate, reproducible and reliable so that the dosimeters
can be calibrated prior to insertion on the day of treatment. The methods examined for
calibration included measurement in two different solid phantoms and a comparison of
results with those calculated by the as treatment planning system (TPS). Monte Carlo is
used to model the different scattering conditions of the calibration phantom and the TPS
and a scatter correction is applied to account for differences in dose as a result of
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contrasting scattering conditions within the two environments. In addition, a direct
calibration of the dosimeters with the TPS is also performed allowing an evaluation of
changes in the response of the dosimeters with energy and depth in the phantom.
Chapter 6, the final chapter, presents a summary and general discussion of the outcomes
and conclusions drawn from this research as well as an outline of future work. It also
provides discussion on limitations and uncertainties in the calibration and measurement
methods.
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Chapter 2:
Literature Review
2.1

The Interaction of Low Energy Photons with Matter

As electromagnetic radiation passes through a medium, interactions between photons and
the atoms in the matter occur resulting in energy being transferred to the medium.
Photons are indirectly ionising radiation as they transfer their energy to electrons in the
atoms of the absorbing medium. Some of these electrons are ejected from the atom with
energy transferred from the incident photon, and in turn, lose their remaining energy by
interacting with other atoms along their path of travel through ionisation and excitation.
The gamma rays emitted from a radioactive source consists of many photons, usually
with a variety of discrete energies. As these photons travel through an attenuating
material, the intensity of the beam is reduced. The intensity I of a narrow monoenergetic
photon beam as it passes through an attenuating medium of thickness t is given by:

I  I 0 exp( t )

(2.1)

where I0 is the initial intensity of the beam incident on the medium and μ is the linear
attenuation coefficient depending on photon energy hν and atomic number Z of the
attenuating medium (Khan 1994). The intensity of the beam I is related to the number of
photons passing through an area, also referred to as photon fluence Φ, and the energy of
these photons E. A quantity known as the energy fluence Ψ describes the radiant energy
passing over this area and is given by Ψ = ΦE. For a source that emits a spectral
distribution of energies, the attenuation through the medium is more complicated due to
the dependence of μ on photon energy and the change in photon spectrum with the
thickness of the medium traversed.
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The three main interactions for low energy photons are the photoelectric effect, Compton
(Incoherent) scattering and Rayleigh (Coherent) scattering. At photon energies greater
than 1.022 MeV, a fourth interaction known as pair production is possible but is generally
not considered to be a low energy photon interaction. Figure 2.1 below shows the
interaction prevalence of the photoelectric, Compton and pair production effects as a
function of photon energy and atomic number Z.

Figure 2.1 Relative importance of the photoelectric effect, Compton scattering and pair
production as a function of photon energy and their dependence on atomic number Z
of the target medium (Anelli 2000).

2.1.1 Photoelectric Effect
The photoelectric effect is the dominant photon interaction process at low energies below
100 keV. The incident photon is totally absorbed by a bound electron in the K, L, M or N
shell of an atom and transfers all of its energy (hυ) to the atomic electron resulting in the
electron being ejected from the atom. The kinetic energy of the ejected electron is equal
to E = hυ-Eb, where Eb is the binding energy of the electron to the atom. After the
electron has been ejected from the atom a vacancy is created in the shell, thus leaving the
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atom in an excited state. This vacancy can be filled by an outer orbital electron with the
emission of characteristic x-ray.

Figure 2.2 Schematic drawing demonstrating how an incident photon interacts with an atom
during the photoelectric effect, ejecting an electron and creating characteristic x-rays
in the process (Khan 1994).

The probability of photoelectric absorption is strongly dependent on the energy of the
incident photon and the atomic number Z of the attenuating medium. As seen in Figure
2.3, an increase in photon energy results in a decrease in the photoelectric cross section
by approximately 1/E3. The exception to this 1/E3 relationship is when the incident
photon has energy that exactly equates to the binding energy of a K, L or M shell
electron. In this case resonance occurs and the probability of photoelectric absorption
dramatically increases.

This effect appears as saw-tooth peaks in the lead curve.

Combining this dependence on photon energy and atomic number Z, the photoelectric
mass attenuation coefficient (τ/ρ) is proportional to Z3/E3 (Khan 1994).
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Figure 2.3 Graph demonstrating the cross section for photoelectric interactions in water and lead
(Khan 1994).

2.1.2 Compton (Incoherent) Scattering
In the Compton process the incident photon, usually with energy much greater than the
electron binding energies to the atom, strikes an atomic electron and ejects it from its
orbit. The electron receives some energy from the photon and is emitted at an angle θ,
while the photon retains a reduced portion of its original energy and is scattered at an
angle  .
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Figure 2.4 Schematic drawing demonstrating how an incident photon is scattered by an atom
during a Compton interaction, ejecting an electron in the process (Khan 1994).

The amount of energy that is retained by the photon depends on the initial energy and the
angle of deflection from the electron. Applying the laws of conservation of energy and
momentum, the following expression can be derived for the energy of the scattered
photon (Khan 1994):

h

h ' 
1

h
(1  cos  )
m0 c 2

(2.2)

where hυ and hυ’ are the initial and scattered photon energies respectively and moc2 is the
rest energy of the electron (511 keV).

2.1.3 Rayleigh (Coherent) Scattering
Rayleigh scattering occurs when a photon interacts with bound electrons in an atom but
no energy is transferred to the atom. The incident photon causes the electrons in the atom
to momentarily oscillate before re-emitting the photon and returning to a stable state. The
photon is re-emitted with the same frequency and wavelength but is scattered at a
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different angle away from the atom. While this interaction does not result in any photon
energy loss, it contributes to the total interaction cross section for low energy photons.

2.2

Deposition of Energy and Absorbed Dose in the Medium

For the photons that interact with the medium that they are passing through, the processes
in which energy is distributed will determine the dose deposited in the medium. In the
interaction process, any energy transferred from photons to electrons can be expended in
two distinct ways:
i.

Through collision interactions with atomic electrons; or

ii.

Through radiative interactions with the medium that slow down the electron and
in turn produce bremsstrahlung photons.

The transfer of energy from photons to electrons is referred to as kerma (or kinetic energy
released per unit mass) and can be divided into collision kerma Kcol and radiative kerma
Krad components. The electrons typically lose their energy in many small interactions
with other electrons depositing dose almost continually along their path as they travel
through the medium. The Krad component does not contribute to energy being deposited
locally as the energy is transferred away from the site of interaction by the
bremsstrahlung photon. For most photon energies used in therapy that interact with
water-equivalent materials, the Krad component is less than 3% (Podgorsak 2005). In the
case of a monoenergetic beam, the collision kerma Kcol at a point in the medium is related
to the energy fluence Ψ at that point by:

 
K col   en 
  

(2.3)

where (µen/ρ) is the mass-energy absorption coefficient for the monoenergetic photons in
the medium. Because electrons travel in the medium and deposit energy along their path,
the absorption of energy (absorbed dose) does not take place at the same location as the
transfer of energy described by kerma. The absorbed dose is defined as the mean energy
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 imparted by ionising radiation to matter of mass m in a finite volume V and given by
the expression:

D

d
dm

(2.4)

The energy imparted  is the sum of all the energy entering the volume of interest minus
all the energy leaving the volume (Podgorsak 2005).

2.3

Intracavity Brachytherapy for Gynaecological Cancer

The most common form of intracavity brachytherapy is the treatment of the uterine
cervix, uterine body and vagina. Since the use of radium in the early 1900’s, radioactive
sources have been inserted into the vagina and uterus for treatment of gynaecological
malignancies with successful outcomes for the patient (MacLeod et al. 1998). The
advantage of gynaecological brachytherapy is that a high radiation dose can be delivered
directly to the tumour, whilst more distant surrounding tissues within the pelvis receive
comparatively less dose due to the rapid fall-off in dose. In the present day, intracavity
brachytherapy combined with external beam radiation therapy (EBRT) is often the
standard treatment for cervical cancer. The EBRT component delivers a homogenous
dose to the primary tumour and potential sites of regional spread and is usually delivered
first to shrink the tumour. This is usually complemented with 3-5 fractions of HDR
brachytherapy either in the middle or end of the course of EBRT and delivers a high dose
to the tumour while reducing dose to the surrounding tissue region.

Brachytherapy has evolved from the early days when treatment was often empirical with
limited understanding of dose and dose distributions, and little knowledge of the
biological effects associated with the treatment. Original treatments were administered
with preloaded applicators but were later superseded by the manual afterloading of
implants. Nowadays, CT/MR compatible applicators come in a wide variety of designs
that are used in conjunction with remote afterloading units. With the development of
15

remote afterloading techniques came the introduction of various radionuclides including
137

Cs and

192

Ir, now used for LDR and HDR brachytherapy respectively. While many

patients with gynaecological cancer are still treated with LDR brachytherapy, there has
been a continuous increase in the number of out-patients receiving HDR treatment.
Modern day HDR brachytherapy using remote afterloading stepping source units in
conjunction with computerised treatment planning provides the ability to achieve a highly
conformal dose distribution to the target volume with good clinical outcomes for the
patient.

2.3.1 Manchester System
As previously mentioned, brachytherapy procedures in the early days were conducted
with little understanding of dose, dose distributions, and duration of implants. As a result
the prescription of dose to the tumour and surrounding anatomy was entirely empirical.
In light of this, it was clear that a dosimetric system or set of rules governing the
administration of treatment in terms of implant type, dose and timing was necessary so
that a prescription could be reproduced for each individual patient.
The first two recognised systems for the treatment of uterine cancer were the Stockholm
system (Heyman 1924) and Paris system (Lenz 1927), both of which used the product of
the total mass of radium (mg) and the duration of the implant (h), for reporting the
treatment. One limitation with prescribing the dose in terms of mg.h was that if the
treatment involved a combination of external beam radiation therapy (specified in terms
of absorbed dose) and brachytherapy, the overall dose delivered by the combined
modalities could not be equated.
To define the dose delivered to a lesion in a more meaningful way than mg.h of radium,
Tod & Meredith (1938) proposed the calculation and reporting of the dose in roentgens at
various points in the pelvis allowing an anatomical comparison of dose to these points
from patient to patient. Obvious anatomical points, such as the external os and the
mucosa of the vaginal vault, were not chosen due to the rapid dose variations in these
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regions.

Instead, points were chosen where the dosage was not sensitive to small

alterations in applicator position. Todd (1938) concluded that the limiting radiation dose
was not the dose to the bladder and rectum, but the dose to the area where the uterine
vessels cross the ureter, known as the ‘paracervical triangle’. Based on this, a point
known as Point A was designated for specifying the dose and the system of sources
proposed was designed to deliver a constant dose rate to this point irrespective of the size
and shape of the uterus and vagina (Godden 1988). This approach formed the basis of
what is known as the Manchester system.
Point A as defined in the Manchester system was originally positioned 2 cm lateral of the
uterine canal and 2 cm superior of the lateral fornix of the vagina in the plane of the
uterus. This was later redefined to be 2 cm superior along the source axis from the lower
end of the inter-uterine tube and 2 cm lateral from the tube. A second reference point,
Point B, was also defined to be 5 cm from the midline and 2 cm superior to the mucus
membrane of the lateral fornix. This point not only gives the dose in the vicinity of the
pelvic wall near the obturator nodes, but also gives a good indication of the lateral spread
of the dose distribution (Thomadsen et al. 2005). A geometric sketch of Point A and
Point B are shown in Figure 2.5.
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Figure 2.5 Diagram demonstrating the location of Point A and Point B in the Manchester
formalism for prescribing dose to the uterine cervix (Thomadsen et al. 2005).

For cases where the uterus does not lie in the midline of the body, the tissues in which
Point A lies are considered to move with the uterus. On the other hand, Point B remains
fixed as its placement does not depend on the uterus itself.
While the Manchester system is the most commonly used reference system for HDR
gynaecological brachytherapy, there has been a recent trend towards volume based
planning.

This change in planning technique has come about in line with

recommendations published by the International Commission on Radiation Units and
Measurement, Report 38 (ICRU 1985). Volume based planning involves delineation of a
planning target volume (PTV) and organs at risk, such as the bladder and rectum. The
advantage offered by volume based planning is that a true representation of the maximum
dose delivered to the organ at risk can be achieved. This is opposed to the usual practice
of placing a single dose point on the plan to approximate what is believed to be the
maximum dose to the organ.

Furthermore, volume based planning can provide
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information on PTV and organ dose by dose volume histogram (DVH), essentially
providing more information on the distribution of dose for these volumes.

2.3.2 Treatment Planning System (TPS)
In modern radiotherapy departments the dose distribution in and around a clinical implant
is calculated using a computerised treatment planning system (TPS). The dose rate
contribution from each dwell point is calculated using a two-dimensional dose calculation
algorithm. These contributions are then summed to determine the total dose rate. The
American Association of Physicists in Medicine (AAPM) recommends using a TPS that
fully complies with the TG-43 formalism (Nath et al. 1995). This algorithm and its
associated parameters are described in detail in the next section. Data for each of these
parameters is usually tabulated within the TPS along with the data relevant for the
specific source type used for treatment.

2.3.3 TG-43 Dose Calculation Formalism
Early brachytherapy dose calculation methods were based on non source specific
quantities such as apparent activity, equivalent mass of radium, exposure rate constants
and tissue attenuation coefficients. They also did not account for differences in internal
construction and encapsulation of various types of sources. In 1995, the American
Association of Physicists in Medicine (AAPM) Task Group No. 43 (Nath et al. 1995)
published a protocol that introduced a new brachytherapy dose calculation formalism.
This protocol, which was later updated in 2004 by Rivard et al. (2004), describes a dose
calculation formalism that uses new dosimetric functions derived from phantom
measurements and Monte Carlo simulation together with realistic source geometry. The


TG-43 protocol expresses the dose rate D at a point in water with coordinates (r,θ) from
the centre of the source with air kerma strength Sk, as:


D ( r , )  S k   

G L ( r , )
 g L ( r )  F ( r , )
GL (r0 , 0 )
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(2.5)

Figure 2.6 Illustration of the geometry used for the TG-43 formalism for the dose calculation of
a line source. Figure taken from Podgorsak (2005).
where:

r

= distance (in centimeters) from the origin to the point of interest P;

θ

= angle between the the radius vector r and the long axis of the source;

Λ

= the dose rate constant, defined as the dose rate to water at a distance of 1 cm
on the transverse axis of a unit air kerma strength source in a water phantom
(the constant, with units in cGy h-1 U-1, is dependent on source geometry,
spatial distribution of radioactivity within the source, encapsulation, selffiltration within the source, and the scattering of photons in water surrounding
the source);

Sk

= air kerma strength, which is a measure of the brachytherapy source strength,
is specified in terms of air kerma rate at a point along the transverse axis of
the source in free space (it is defined as the product of air kerma rate at a
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calibration distance in free space K (d ) , measured along the transverse
bisector of the source, and the square of the distance d):


S k  K (d )  d 2

(2.4)

The units are commonly denoted as µGy m2 h-1, or U, which is 1 unit of air
kerma strength;

G(r,θ) = the geometrical function accounts for the variation in relative dose due only to
the spatial distribution of activity throughout the source. It does not include
the effects of photon absorption and scattering within the source;
(ro,θo) = the reference point (ro,θo) which lies on the transverse bisector of the source at
a distance of 1 cm from its centre, i.e. ro = 1 cm and θo = π/2;

F(r,θ) = the anisotropy function accounts for angular variation of the dose distribution
around the source due to absorption and scattering of photons by the
encapsulating material and the surrounding medium; and

g(r)

= the radial dose function defines the fall-off of dose rate along the transverse
axis due to absorption and scattering in the medium. It is also influenced by
filtration of photons by the encapsulation and source materials.

2.4

Iridium-192 Source

Iridium-192 (192Ir) is a common source used for HDR brachytherapy treatment. It can be
produced in the form of a wire or small radioactive seeds. The

192

Ir radioisotope is

produced when stable 191Ir absorbs a neutron via neutron capture usually within a reactor
environment.

192

Ir has a half-life of 73.83 days and decays primarily by β-emission and

electron capture to excited states of

192

Pt and

21

192

Os respectively (Nath et al. 1995).

Subsequently, the daughter nuclei decay to the ground state by γ-ray emission.

192

Ir has a

rather complex decay scheme emitting γ-rays with a range of about 40 discrete energies
between 50 keV and 800 keV. The average energy of the emitted photons from an
unencapsulated source is approximately 397 keV as stated in the International Atomic
Energy Agency report TEC-DOC-1274 (IAEA 2002). A list of the most prominent
photon energies emitted from an unencapsulated

192

Ir source is given in Table 3.1 in

Chapter 3.

2.5

Imaging in Gynaecological Brachytherapy

Conventional imaging for gynaecological intracavity brachytherapy made use of two
orthogonal plane radiographs.

While this method was effective in localising and

reconstructing source positions based on radiographic markers, differentiation between
the soft tissue targets and the surrounding uterus, bladder and rectum proved very
difficult. Computed tomography (CT) has served as the major imaging modality for
external beam treatment planning and in more recent times has become common practice
for brachytherapy treatment planning as well. Although CT does not have as high a
resolution as plain film radiography, it provides images that show sufficient soft tissue
contrast to delineate target tissues as well as surrounding organs at risk. The GECESTRO recommendations (Gerbaulet et al. 2002) also suggest the use of magnetic
resonance imaging (MRI) where available for brachytherapy treatment planning. MRI
provides excellent soft tissue contrast to not only allow accurate delineation of the
bladder and rectum, but clear identification of the primary tumour and the extent of
cancer spread into the cervix. The availability and costs of MRI often mean that this
modality is not widely used for the purposes of treatment planning.

2.6

Rectum and Bladder Complications in High Dose Rate
Brachytherapy

High Dose Rate (HDR) brachytherapy in conjunction with external beam radiation
therapy has become common practice for treatment of carcinoma in the uterine cervix.
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While this approach has been recognised as one of the most effective treatment
modalities for this type of cancer (Le Pechoux et al. 1995; Perez et al. 1986), the
increased risk of late complications to the rectum and bladder associated with HDR
brachytherapy component have been reported in the literature (Montana & Fowler 1989;
Ogino et al. 1995). While intracavity HDR brachytherapy allows a large dose to be
delivered to the uterine cavity, the close proximity of these critical organs to the treated
area can result in the organs receiving a significant dose that may lead to tissue
complications. Early complications can include inflammation of the rectum (proctitis)
and bladder (cystitis), while late effects can result in strictures, rectal bleeding and the
development of a rectal fistula. These complications have an adverse effect on the
patient’s quality of life and may result in post-treatment surgery (Vistad, Fossa &
Dahl 2006).
The risk of complication increases with the cumulative dose delivered to the organ.
Clinical studies, such as those mentioned below, have proposed dose tolerance levels for
the rectum and bladder based on recorded patient data. These retrospective studies
examined the severity of rectum and bladder complications with respect to the dose
delivered to Point A using HDR brachytherapy, external beam therapy or a combination
of both modalities (Chen et al. 1991; Montana & Fowler 1989; Roman et al. 1991).
Montana & Fowler (1989) found that a dose of 75 Gy delivered to Point A resulted in a 5
to 10% frequency of cystitis and a 10% chance of proctosigmoiditis, with the rate of
complications increasing significantly with higher doses.

Similarly, Eshe, Crook &

Horiot (1987) and Pourquier, Dubois & Delard (1982) showed that the frequency and
severity of proctitis increased with cumulative rectum dose and volume treated, based on
dose-volume relationships.
As discussed in the sections to follow, real-time in vivo dosimetry provides information
on dose delivered to these critical organs. By measuring the dose in vivo, the risk of
overdosing the rectum and bladder is decreased, which in turn will lead to a decrease in
the early and late complications experienced by patients undergoing HDR brachytherapy.
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2.7

In Vivo Dosimetry

In vivo dosimetry is a way of independently verifying that the dose delivered during
treatment corresponds with the dose prescribed in the treatment plan. It can also provide
information on the dose delivered to critical organs to avoid early and late tissue
complications.

In vivo dosimetry is especially useful in high dose rate (HDR)

gynaecological brachytherapy due to the high doses delivered immediately surrounding
the source and the close proximity of the rectum and bladder to the implant. The doses
that these critical organs are expected to receive during the treatment is usually calculated
by the treatment planning system (TPS). However, there are well known limitations to
this calculation mainly due to the non-consideration of heterogeneity by the TPS. Kwan
et al. (2009) measured 14.7% less dose to the anterior rectum wall than what was
predicted by the TPS due to air in the rectum. In light of this, the implementation of a
well calibrated in vivo dosimetry system can provide quantitative dose information on the
doses delivered to the organs at risk that are independent of the TPS.
There are a wide range of radiation detectors that have been proposed for in vivo
dosimetry in brachytherapy.

Diodes and MOSFETs are two of the more common

dosimeters available for brachytherapy and are the two types of detector chosen for this
work. The use of these detectors is discussed further in the sections to follow, while
literature is also available on TLDs, diamond detectors, and scintillation dosimeters
employed for brachytherapy (Das et al. 2007; Lambert et al. 2007).

2.7.1 Diode Dosimetry
Silicon diodes have been used as radiation detectors for many years and more recently as

in vivo dosimeters in external beam radiation therapy and brachytherapy. Their high
spatial resolution, high sensitivity, absence of external bias and ability to provide realtime measurement make them a suitable detector for in vivo dosimetry.
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2.7.1.1 How a Diode Operates as a Radiation Detector
A p-type diode is formed by doping impurities of a donor element (group V), with at least
two orders of magnitude higher concentration, into a p-type substrate. Similarly, an ntype diode is formed by doping impurities of an acceptor element (group III) into an ntype substrate. That is, whether a diode is called an n-type or p-type is determined by the
material type of the substrate. In each case the excess carriers from each side diffuse to
the opposite side creating an internal electric field which prevents further diffusion. This
spatially charged region is known as the p-n junction or depletion region. The internal
electric field across the junction enables the collection of radiation generated minority
carriers, measured on an electrometer, without an external bias being applied. Incident
ionising radiation generates electron-hole pairs in the silicon. The portion of minority
carriers that reach the p-n junction define the diffusion lengths Lp and Ln and are then
swept across the junction by the internal electric field to be collected by the electrometer
(Shi, Simon & Zhu 2003). This process is shown below in Figure 2.7.

Figure 2.7 Schematic diagram of a silicon p-n junction diode and its function as a radiation
detector (Shi et al. 2003).
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2.7.1.2 Characteristics of Diodes
There are a wide range of semiconductor diode detectors commercially available for
relative dosimetry in megavoltage radiation beams. Their small size and high spatial
resolution make diode detectors extremely useful for measuring dose in steep dose
gradient regions such as those present around a HDR brachytherapy source.
Other advantages of diodes include:
i.

their small size and light weight make them easy to place in or on any area
of the patient;

ii.

they are mechanically stable with relatively good reproducibility;

iii.

they exhibit minimal radiation field perturbation;

iv.

they provide instantaneous readout without requiring an external bias; and

v.

they are inexpensive to manufacture and produce in bulk.

However, like all detectors they also have their own limitations that include:
vi.

a known angular dependence which often depends on the shape and design
of the diode;

vii.

a temperature dependence that leads to a different response at room and
body temperature;

viii.

energy dependence with some diode designs showing a significant change
in response between kilovoltage and megavoltage x-ray energies; and

ix.

a degradation in sensitivity with accumulated dose.

Silicon diodes have been used by Kirov et al. (1995) for measuring the dose distributions
around a

192

Ir HDR source.

The results showed good agreement with previously

published TLD and ionisation chamber data by Baltas, Kramer & Loffler (1993) for
anisotropy and dose rate functions. This data was later compared with Monte Carlo
simulations to validate the Monte Carlo data.
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Clinically, semiconductor diodes have been implemented in brachytherapy for real-time

in vivo dosimetry in the form of a single detector or diode array (Alecu & Alecu 1999;
Waldhausl et al. 2005). A study performed by Waldhausl et al. (2005), used the same
PTW diode probes implemented in this work to measure and compare the dose to the
rectum and bladder with the dose predicted by the treatment planning system.
Differences between the planning system and measured data for 55 patients were
presented showing a difference of -31% to +90% for the rectum and -27% to +26% for
the bladder.

The inherent properties of the diode probes were also evaluated for

reproducibility, linearity, angular dependence and temperature dependence giving an
overall uncertainty of ±7% in dose measurement.

2.7.2 MOSFET Dosimetry
It was suggested as early as 1974 that the structure of a metal oxide semiconductor
(MOS) device could potentially measure cumulative exposure to ionising radiation.
While the metal oxide semiconductor field effect transistor (MOSFET) is rather small in
size and relatively insensitive compared to other methods of measurement, this device has
been effectively used as an integrating dosimeter for applications in space as well as in
the medical field for the measurement of exposure to X-rays and gamma rays (Ma &
Dressendorfer 1989).

2.7.2.1 The Operation of a MOSFET
A Metal Oxide Semiconductor Field Effect Transistor (or MOSFET) is an electronic
device with four terminals; the source (S), the drain (D), the gate (G) and a silicon
substrate. The first three terminals sit on top of the silicon substrate which is doped with
impurities to make either a p-type or n-type semiconductor (Figure 2.8). The source
terminal is usually grounded and a positive voltage is applied to the gate. The positive
gate voltage causes the free positively charged holes inside the p-type substrate to be
repelled away from the region under the gate resulting in a carrier depletion region. This
gate voltage also attracts the moveable electrons from the n-type regions below the source
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and drain forming a conduction channel region underneath the gate allowing current to
flow. For the general operation of the MOSFET, a certain voltage is required to allow a
fixed and stable current flow between the source and drain terminals. The minimum gate
voltage required to achieve this fixed current is known as the threshold voltage (VTH).
The gate is insulated from the conducting channel by a thin layer of silicon-oxide (SiO2).
This SiO2 layer is the radiation sensitive region important for measuring radiation dose.
The MOSFET device can also be built with p-type regions lying underneath the source
and drain in an n-type silicon substrate. These devices behave in a similar but opposite
fashion in regard to the movement of electrons and holes.

Figure 2.8 Schematic diagram of a Metal Oxide Semiconductor Field Effect Transistor
demonstrating the depletion region as a result of the positively charged gate and the
subsequent

induction

channel

between

Dressendorfer 1989).
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2.7.2.2 Effects of Ionising Radiation on MOSFET Devices
When an ionising particle passes through the MOSFET, electron-hole (e-h) pairs are
generated in the gate, substrate and the oxide layer. The number of pairs created is
proportional to the quantity of energy deposited in the material, which is expressed
through the total absorbed dose. In the metallic gate and silicon substrate the e-h pairs
quickly disappear due to the low resistance of these materials and have no effect on
radiation measurement. In the silicon-oxide (SiO2) layer, a fraction of the radiationinduced e-h pairs recombine almost immediately (within picoseconds) after being created
while those that do not recombine are free to move in the SiO2 in response to an induced
or applied electric field. At room temperature, electrons in the SiO2 have a relatively high
mobility compared with holes and are rapidly swept out of the oxide and collected at the
positive gate electrode (under positive gate bias).

Figure 2.9 Schematic illustration of the effects induced by ionising radiation in the SiO2 layer
under positive gate bias (Anelli 2000).
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The holes remaining in the SiO2 layer that have not recombined with an electron remain
near their point of generation. This leads to a net positive charge in the oxide while some
of the holes are transported in a stochastic fashion toward the SiO2 – Si interface. As
shown in Figure 2.9, the radiation-induced holes that have completed crossing the oxide
can be either trapped close to the SiO2 – Si interface or can recombine with electrons
from the silicon substrate. The trapping of holes in the oxide and at the interface leads to
a negative threshold voltage shift ΔVTH (Figure 2.10), reflecting the amount of energy
that the MOSFET has absorbed from the ionising radiation. The difference in voltage
shift before and after irradiation can be measured and is proportional to the absorbed dose
(Anelli 2000).

Figure 2.10 Shift in threshold voltage in the MOSFET after irradiation (Ma & Dressendorfer
1989).

2.7.2.3 Characteristics of the MOSFET
The potential use of MOSFETs as a dosimetric tool for modern radiation oncology
modalities has been widely researched and published in the literature. The MOSFET
poses as a versatile dosimeter that can be used for many applications in radiotherapy
including conformal radiotherapy, intensity-modulated radiation therapy (IMRT), hadron
therapy and microbeam radiation therapy (Rosenfeld 2002). MOSFET detectors have
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many advantages over traditional dosimetry tools that also make them attractive for use
as in vivo dosimeters for HDR brachytherapy. These include:
i.

their small size and mass make them easy to place in any area of the body;

ii.

their small sensitive volume results in extremely good spatial resolution in the
order of 1 μm;

iii.

they don’t require any post-irradiation processing or annealing;

iv.

they retain their dose history in that the threshold voltage VTH readout is related
to the total accumulated dose delivered to the device;

v.

they can provide real-time dosimetry allowing the accumulated dose during
treatment to be quantitatively determined; and

vi.

they are dose rate independent as well as independent of energy above 300 keV
(Zilio et al. 2006).

However, with appropriate calibration they can be

successfully used at lower therapeutic energies (Cheung, Butson & Yu 2003).
Some limitations of MOSFET devices for radiation dosimetry include:
vii. a shift in threshold voltage (VTH) associated with a change in ambient
temperature. Cheung, Butson & Yu (2004) found that in order to provide stable
dose measurements the dosimeters should be at thermal equilibrium for both the
initial and final threshold voltage readouts; and
viii. the strong angular dependence of some commercial MOSFETs, which have
shown variations in response as large as ±5.5% around an

192

Ir source

(Kinhikar et al. 2006) and 11 to 28% for megavoltage energies (Ramani, Russell
& O'Brien 1997).

2.8

Monte Carlo

Monte Carlo has become an important tool in radiotherapy physics and radiation
dosimetry to model photon and electron interactions with matter. Monte Carlo simulates
radiation effects on a particle by particle basis in a geometrical environment constructed
by the user. Each particle is traced from its point of origin until it loses all its energy and
is absorbed in the medium. As the particle traverses through each medium it undergoes
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many interactions resulting in deposition of energy and scattering, all of which are
tracked during the simulation. The probability of photon and electron interactions in each
medium is governed by cross-sectional database inbuilt into the code. As the primary
particle travels through and interacts in the media, secondary particles are also created
and followed along their individual paths until they are absorbed as well. Each simulated
primary particle produces one history. Simulating a large number of histories yields
information on a number of measurable quantities on a macroscopic scale. Data can be
obtained on absorbed dose per incident particle, relative contribution of a particle type to
the dose, KERMA, particle fluence, and spectral information for any location in the user
defined geometry. The statistical uncertainty associated in a sample is proportional to

1 / N , where N is the number of particle histories simulated in the sample. There are
numerous Monte Carlo codes employed for modelling radiation produced by linear
accelerators, cobalt machines and brachytherapy sources. Some of the more common
codes include ETRAN (Electron TRANsport) and EGS (Electron Gamma Shower), the
latter being utilised in this work.

2.8.1 Electron Gamma Shower (EGS)
EGS (Electron Gamma Shower) is a Monte Carlo computer code that can operate on
either Windows or Unix/Linux systems. The code is written in an extension of the
FORTRAN language known as MORTRAN. MORTRAN uses a set of macros making
the code more readable and user friendly. Prior to compilation, the MORTRAN code is
fed through a processor that translates it into FORTRAN.
The EGS code simulates the interactions of photons, electrons and positrons with matter
with energies ranging from 1 keV up to thousands of GeV. The first version of the code
released in 1978 (EGS3) was developed by Ford & Nelson (1978) at the Stanford Linear
Accelerator Centre. The code was then upgraded to EGS4 by Nelson, Hirayama &
Rodgers (1985), to improve the particle transport model and make the system more
flexible and efficient. EGS4 has become one of the most widely used Monte Carlo codes
in medical physics and has been employed by many authors to generate benchmark dose
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distributions with which to compare other dose calculation methods and clinically
measured data.

2.8.1.1 EGSnrcV4
The EGSnrc Monte Carlo package is an updated and modified version of the EGS4
system developed by the National Research Council (NRC) of Canada. This version is
available in a multi-platform environment (EGSnrcMP) with a number of graphical user
interfaces (GUIs) to run simulations and manipulate the geometrical environment.
EGSnrcMP was the version used throughout the Monte Carlo component of this thesis.
The updated code includes a new electron transport algorithm PRESTA-II (Parameter
Reduced Electron Step Transport Algorithm), a new multiple scattering theory and many
other improvements that are listed in the EGSnrc system manual. Furthermore, the
inaccuracies associated with the modelling of low energy photons in EGS4 have been
addressed to provide accurate modelling of photons with energies as low as 1 keV
(Kawrakow & Rodgers 2006).
The following physical processes are taken into account by the EGSnrc system:


Photoelectric Effect;



Compton Scattering;



Pair Production;



Rayleigh Scattering;



Bremsstrahlung production;



Positron Annihilation;



Multiple scattering of charge particles by Coulomb scattering from nuclei;



Continuous energy loss for charge particles between interactions;



Electron spin effects for electron elastic scattering;



Moller (e- e-) and Bhabha (e+ e-) scattering; and



Characteristic X-rays (K, L, M shells) and Auger electrons following atomic
relaxation.
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The EGS code consists of two subroutines HATCH and SHOWER that are called by the
user. These in turn call other subroutines in the EGS code as well as three user specified
subroutines HOWFAR, HOWNEAR, and AUSGAB. The three subroutines mentioned
above along with the MAIN program make up the USER code section, which is
manipulated by the user to specify all the input parameters required for the simulation.
Figure 2.11 illustrates the subroutines incorporated under the EGS layer and USER layer
of the code. The user codes can communicate with the EGS codes through the use of
common variables such as medium information, cut-off energies and distance units
(Kawrakow & Rodgers 2006).

Figure 2.11 Subroutines for ‘Hatching’ simulations in the EGSnrc Monte Carlo Code (Kawrakow
& Rodgers 2006).
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As mentioned above, the MAIN program is the portion of the USER code manipulated by
the user. The MAIN program executes the following operations in sequence:


Performs initialisation needed for the geometry routines HOWFAR and
HOWNEAR and sets values of common variables;



Calls the HATCH subroutine to initialise and read material data for the media
created in PEGS; and



Calls the SHOWER subroutine resulting in the generation of one history and the
associated secondary particle cascade. Once the cascade is complete, the MAIN
program calls SHOWER and the process is repeated for the chosen number of
histories.

The subroutines HOWFAR and HOWNEAR specify the geometry of the system. Using
the cross-sectional data for a chosen medium, HOWFAR calculates the distance the
particle will travel before an interaction occurs and determines whether the particle
crosses any geometric boundaries in the process.

On the other hand, HOWNEAR

calculates the perpendicular distance from the particle’s current position to the closest
region boundary. Following every interaction, the subroutine AUSGAB is called to score
and output the information provided on particle type, energy, position and direction of
travel (Kawrakow & Rodgers 2006).

2.8.1.2 PEGS4
Prior to performing any simulation in EGS, interaction cross-section data for all media
used in the scoring geometry must be compiled in PEGS (Preprocessor for EGS), which
in turn formats the data for direct use in EGSnrc. PEGS generates cross-sectional data
for elements with atomic numbers ranging from 1 to 100 as well as compounds and
mixtures selected by the user to be used in the simulation. The cross-section data used by
PEGS is taken from tables contained in the Hen_House folder and comply with those
adopted by ICRU Report 37 titled “Stopping Powers for Electrons and Positrons”
(ICRU 1984). The user also specifies the range of energies to be included in the crosssection data for each medium with the threshold parameters AP and UP for the lower and
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upper photon cut-off energies respectively and AE and UE for the lower and upper
charged particle energies respectively. It is important to note that the charge particle
threshold energies include the rest mass of the particle, so for an electron cut-off of
10 keV than the AE value is actually 521 keV (i.e. the rest mass of the electron is
511 keV).

Figure 2.12 Screenshot of the PEGS GUI on the EGSnrcMP environment (Rodgers et al. 2005)

2.8.1.3 DOSRZnrc
DOSRZnrc is the main code for simulating dose deposition in the EGSnrc system. This
code simulates both photon and electron sources in a cylindrical geometry divided into
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scoring regions defined by the user. Following the simulation, the code outputs statistical
data for all scoring regions for interpretation and analysis.

Before initialising a

simulation the user must enter a set of variable parameters that define such things as the
source dimensions and spectrum, scoring geometry, materials and the interactions
simulated. In addition the user must specify what information is to be included in the
output file. For the EGSnrcMP user code these parameters are entered on a graphical
user interface (GUI) as shown below and make up the input file for the MAIN program.

Figure 2.13 Screenshot of DOSRZ GUI for manipulating transport parameters in EGSnrcMP.
The user works their way through the other tabs along the top row of the screen to
define the input/output style, number of histories, geometry of the scoring regions,
and the source type and design (Rodgers et al. 2005).
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The user defined parameters that make up the input file establish the following platforms
for the simulation (Rodgers et al. 2005):


Defines the location, shape and dimensions of the source as well as the type and
energy of the radiation emitted including whether the radiation is monoenergetic
or consists of a spectrum;



Defines the size of scoring regions surrounding the source in right cylindrical
geometry as well as the material contained in each region;



Specifies the transport controls to be considered in the simulation including
maximum step sizes, minimum energy cut-offs and interaction processes;



Defines the number of histories to be scored and also sets a limit for the maximum
CPU hours or the statistical accuracy sought for the simulation; and



Specifies the type and form of the output data including tables and plotting files.

2.8.1.4 FLURZnrc
The remaining RZ codes in the EGSnrc system are similar in many ways to the
DOSRZnrc code in regard to source and geometric set-up with a slight change in output
data. The FLURZnrc code scores the fluence of different particles in each region using
the same cylindrical geometry described in the previous section. The energy fluence
spectrum can be obtained at any point from the source by creating energy bins to score
the fluence. The fluence in each region is calculated using the total pathlength in a given
energy bin divided by the volume of the region. The fluence output data for each energy
bin includes the fluence for a range of particles including primary and secondary photons
and electrons.

38

Chapter 3:
Monte Carlo Modelling of the Dose
Distribution and Photon Spectra along the
Transverse Axis of an 192Ir Source
3.1

Introduction

Computational dosimetry techniques such as Monte Carlo have played an important role
in establishing what is termed ‘reference-quality’ dose distributions used to implement
the TG-43 dose calculation formalism. In fact, most of the dosimetry datasets for low
energy brachytherapy sources included in the revised TG-43 protocol (Rivard et al. 2004)
are based purely upon Monte Carlo assessment of the radial dose and anisotropy
functions. While the TG-43 reports (Nath et al. 1995; Rivard et al. 2004) contain
reference-quality datasets for a range of low energy interstitial brachytherapy sources
commercially available, they do not include equivalent datasets for remote afterloading
192

Ir sources used in HDR brachytherapy. Li et al. (2007) have published guidelines

recommended by the AAPM and ESTRO groups for characterising new HDR
brachytherapy sources intended for clinical use. These guidelines state that the source
dosimetry data should be presented in accordance with the revised TG-43 formalism and
the source dose distribution used for treatment planning should be based upon two dose

rate D(r ) determinations; a theoretical calculation such as Monte Carlo as well an
experimental based measurement.

The source data obtained from Monte Carlo

simulation for parameters such as the anisotropy function and dose rate constant are
usually compared with measured data obtained with TLD or diode dosimetry (Kirov et al.
1995). In addition to existing LDR seed source datasets (Williamson 1991), Monte Carlo
and experimental dosimetry data for a range of commercially available HDR and PDR
remote afterloading sources have been published by various authors (Daskalov, Loffler &
Williamson 1998; Williamson & Li 1995) to characterise the dose rate distributions
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around these sources in accordance with the parameters used in the TG-43 formalism.
The dosimetry data published by Williamson & Li (1995) for the microSelectron HDR
‘Classic’ source is utilised for dose calculation in the NucletronTM PLATO treatment
planning system used throughout this work.
When using any type of device for radiation dosimetry, it is imperative to understand the
inherent properties of the device that may influence its ability to accurately measure dose.
In the case of silicon detectors such as diodes and MOSFETs, one well established
limitation is their energy dependence that can result in an over-response at low photon
energies in the range of 100 keV and below (Edwards et al. 1997; Kron et al. 1998; Zilio
et al. 2006). Meli, Meigooni & Nath (1988) and Meigooni, Meli & Nath (1988) have
also indicated that the energy spectrum of an

192

Ir source progressively changes with

distance from the source resulting in an increased proportion of low energy photons in the
spectrum.

This reported change in energy spectrum will potentially have an impact on

the method of calibration for the PTW diodes and the MOSkinTM. While the proposed
method of calibration in this report involved a simultaneous irradiation of the diode
probes and MOSkinTM with an ionisation chamber at a distance of 8 cm from the source,
it was important to understand how this energy response would affect the clinical
measurements at 1 to 2 cm from the source.
The EGSnrc Monte Carlo code was used to further investigate how the

192

Ir spectrum

changes with depth in a phantom and assess what effects this may have on the response
of the silicon diode and MOSFET detectors. The EGS code is well benchmarked by the
AAPM for modelling brachytherapy sources (Rivard et al. 2004) and served as a useful
tool for gaining a better understanding of the dose and spectral distributions along the
transverse axis of the 192Ir source.
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3.2

Materials and Methods

3.2.1 Modelling an

192

Ir Source within the EGSnrc Monte Carlo

Code
The source employed throughout the entire study was the NucletronTM microSelectron
‘Classic’ high dose rate (HDR)

192

Ir source. For ease of reference the source will be

referred to as the ‘Classic’ source for the rest of the chapter. The ‘Classic’ source was
modelled using the RZ cylindrical geometry of the EGSnrc code.

The cylindrical

symmetry of this source meant that the geometry employed in the code could model most
aspects of the source with the exception of the rounded source tip. The active region of
the source was modelled by a uniform isotropically radiating disk inherent to the code
and with dimensions defined by the parameters RMINBM and RBEAM for the inner and
outer radii of the source respectively, and ZMIN and ZMAX for the length of the source in
the Z direction within the geometry. The core region of the source consists of a 3.5 mm
long cylinder of pure iridium with a diameter of 0.6 mm (density 22.42 g cm-3) within
which the radioactive

192

Ir is assumed to be uniformly distributed. This active core is

encapsulated by an AISI 316L stainless steel capsule of length 5 mm and outer radius of
1.1 mm that is welded on to the end of a steel cable. The capsule and cable components
used in the model were taken from PEGS4 data for AISI 316L stainless steel which has a
density of 8.06 g cm-3 and is composed of: Fe 68.8%, Cr 17%, Ni 12%, Mo 2.5%, Mn 1%
and Si 0.7% (Williamson & Li 1995). Two approximations to the geometry of the real
source were made in the Monte Carlo source model displayed in Figure 3.1. Firstly, the
hemispherical shape at the distal end of the real source capsule has been ignored and
modelled as a flat end. Secondly, the cable attached to the other end on the source
capsule has only been modelled to be 2 mm in length. It is assumed that both these
approximations will have negligible effect on the dose scored along the transverse axis of
the source. This assumption is based on the low probability for photons to be scattered in
a direction 180° to the angle of incidence and back onto the transverse axis. Therefore
replacing the existing water regions at the tip and cable ends with a small amount of
stainless steel would be unlikely to result in a measurable difference in the dose scored on
the transverse axis.
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Figure 3.1 Schematic representation of the

192

Ir microSelectron HDR ‘Classic’ source as

modelled in EGSnrc Monte Carlo code including all dimensions and materials used
in the source core and encapsulation.

The

192

Ir spectrum utilised in all simulations was that of a bare

192

Ir source,

Ir192_bare_1993, published by Duchemin & Coursol (1993) with an average photon
energy of 345 keV. This spectrum has been employed by a number of authors (Borg &
Rodgers 1999) for modelling a variety of HDR brachytherapy sources. The components
of this spectrum are shown in Table 3.1. The source core and surrounding encapsulating
material attenuate the photons emitted from the

192

Ir nuclide resulting in a modified

spectrum outside the source. Furthermore, the spectrum is expected to change with
distance travelled through the surrounding medium as the photons undergo multiple
scatter interactions.

42

Table 3.1

Photon Spectra for the Ir192_bare_1993 source taken from the appendix of (Borg &
Rodgers 1999).

Energy interval
or bin
(keV)

Photons in bin
per 100 decays
(%)

7 - 14

5.8

61 - 67

10.72

71 - 79

2.892

136 - 137

0.181

201 - 202

0.485

205 - 206

3.33

283 - 284

0.266

295 - 296

28.85

308 - 309

30.05

316 - 317

82.8

374 - 375

0.721

416 - 417

0.664

468 - 469

47.8

484 - 485

3.16

489 - 490

0.427

588 - 589

4.48

604 - 605

8.16

612 - 613

5.26

884 - 885

0.288

Total
(photons / decay)

2.363
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3.2.2 Scoring Geometry along the Transverse Axis of an

192

Ir

Source in EGSnrc
The user code DOSRZnrc was used to simulate the dose deposited along the transverse
axis of an 192Ir source placed at the centre of a cylindrical water phantom. To ensure full
scattering conditions, the cylinder was constructed to have a radius of 30 cm and a height
of approximately 20 cm. The phantom was divided up into a number of volumetric
scoring regions in the shape of annuluses as shown in Figure 3.2 taken from Russell &
Ahnesjo (1996). Note that this figure demonstrates the scoring geometry for the EGSnrc
Monte Carlo calculations but does not depict the true dimensions of the cylindrical
phantom described above.

Figure 3.2 The cylindrical scoring geometry for the EGSnrc Monte Carlo calculations. The
cylindrical water phantom is divided into a number of annuluses of thickness Δz and
radial width Δrcyl (Russell & Ahnesjo 1996).
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The dimensions of the scoring regions in the simulation were chosen to have a radial
thickness Δrcyl and axial thickness Δz of 1 mm x 1 mm. These annuluses were positioned
in line with the centre of the source and spaced every 5 mm along the transverse axis of
the source to a distance of 10 cm. Beyond a distance of 10 cm from the source centre,
where there is a decrease in the dose gradient, the distance between each scoring region
was extended to 1 cm (up to a distance of 15 cm from the source) and then 5 cm (out to
25 cm from the source) to reduce simulation time. A total of 109 photon histories were
run for each Monte Carlo simulation taking a total of approximately 5 hours to compute
and providing sufficient statistical accuracy with an uncertainty of less than 2% in all
scoring voxels of interest.

Photon interactions simulated included photoelectric

absorption, bound Compton scattering, pair production, Rayleigh scattering and atomic
relaxations. These interactions were simulated down to the global photon cut-off energy
(PCUT) of 10 keV, while the electron threshold (ECUT) was set to 521 keV to include
the rest mass of the electron.
To simulate the dose deposited in the diodes and the MOSFET, a 1 mm x 1 mm scoring
region composed entirely of silicon was placed within the water phantom at a designated
distance from the source (Figure 3.3). Individual simulations were run for each position
of the silicon voxel along the transverse axis. The silicon voxel used to model the diodes
and MOSFET in each scoring region has a much larger volume than the micron sized
sensitive volume in each of these detectors and does not depict the true composition of
these devices. However, it provided a reasonable approximation of dose deposition in
silicon that could be later compared with dose in water.
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Figure 3.3 Zoomed in view of the water phantom geometry with a silicon scoring voxel located
at a distance of 1 cm from the centre of the 192Ir source on the transverse axis.

3.2.3 Calculating Photon Spectra for the

192

Ir ‘Classic’ Source

using EGSnrc
In order to gain a better understanding of how the photon spectra changed with distance
from the source as well as the effects of the attenuating source encapsulation material, the
FLURZnrc user code was employed to simulate the spectra of the primary and scattered
photons surrounding the source. Simulations were performed both in air and water for
the source described in Section 3.2.1 and in the same size phantom used for scoring dose
in Section 3.2.2. The photon energy fluence was evaluated on the transverse axis at three
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positions away from the centre of the source: 1 cm; 5 cm; and 10 cm. The fluence
scoring regions along the transverse axis had a thickness Δr of 0.1 mm and height Δz of
0.1 mm. The total energy fluence in each region was scored in 5 keV energy bins for the
full range of the

192

Ir spectrum. For the purpose of calculating the air kerma strength Sk

of the modelled source, the electron transport cut-off energy ECUT was set to 2 MeV so
that all energy transferred to electrons was deposited at the point of interaction resulting
in no bremsstrahlung contribution to the source spectrum and calculated air kerma
strength.
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3.3

Results

The results of the EGSnrc Monte Carlo simulations for the DOSRZnrc and FLURZnrc
user codes are presented in the sections to follow.

3.3.1 DOSRZnrc
The DOSRZnrc user code was used to score the dose deposited in the water phantom
along the transverse axis of the modelled

192

Ir ‘Classic’ source. Figure 3.4 shows a plot

of the Monte Carlo data for dose in water along the transverse axis of the ‘Classic’ source
normalised at 1 cm. Also displayed for comparison is the data published in the literature
by Williamson & Li (1995) for the same source model. The Monte Carlo data is within
2% agreement with the published values across the whole data range. The data published
by Williamson & Li (1995) also includes the TG-43 parameters for the ‘Classic’ source,
which are incorporated into the PLATO treatment planning system used throughout this
study.
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Figure 3.4

Monte Carlo simulated dose in water along the transverse axis of the ‘Classic’ source
compared with the dose distribution published by Williamson & Li (1995) for the
same source (normalised at 1 cm).

In addition to simulating dose in water, dose was also scored separately in an identical
phantom made of PMMA to emulate the PTW calibration jig material that would be later
used to calibrate the diode probes and MOSFET for in vivo dosimetry. Figure 3.5 shows
the relative dose deposited in each scoring region within the respective water, silicon
voxel in water, and PMMA phantoms. The curve is plotted in terms of Gy per source
particle as a function of distance from the centre of the source.
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Figure 3.5 Depth dose curves comparing the dose deposited in water and PMMA phantoms as
well as the dose scored in silicon voxels within the water phantom. The dose is
plotted as a function of distance from the centre of the ‘Classic’ source.

From Figure 3.5 it is evident that the total dose deposited in the silicon voxel close to the
source is almost equal to the dose deposited in the water phantom. However, beyond the
first few centimeters from the source, the silicon voxel and water depth dose curves
diverge indicating an increase in the dose deposited in the silicon voxel compared to
water. Table 3.2 shows the ratio of dose to silicon (DSi) to dose in water (DWtr). The ratio
becomes rapidly larger after the first few centimeters and the dose in silicon is as much as
73% higher than the dose in water at a depth of 25 cm in the phantom. At a depth of
8 cm, corresponding to the depth of calibration in the PMMA jig, the difference between
dose in silicon and water is 25%.
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Table 3.2

Ratios of dose in silicon voxels and PMMA with respect to water as a function of
distance from the centre of the ‘Classic’ source.

Distance from centre of

1

5

8

10

20

25

Ratio DSi / DWtr

0.94

1.14

1.25

1.36

1.69

1.73

Ratio DPMMA / DWtr

0.96

0.97

0.91

0.93

0.84

0.82

source (cm)

This difference between dose in silicon and water observed at larger distances from the
source is attributed to an increase in low energy scattered photons present at larger depths
in the phantom. It is also attributed to the strong dependence of the photoelectric effect
on the effective atomic number (Z) of the material in which energy is deposited.
Recalling from Chapter 2, the probability of the photoelectric effect is proportional to
Z3 / E3; silicon has an atomic number Z = 13, while the effective atomic number of water
is Zeff = 7.51 (Metcalfe, Kron & Hoben 1997). Comparing the dose scored in the PMMA
phantom to that in the water phantom, it appears that at distances further from the source
the dose in PMMA is slightly less than that deposited in water. This is attributed to the
greater attenuation of photons in the denser PMMA medium. However, this is generally
balanced with an increase in scatter dose.
DOSRZ also allows the user to divide up the scored dose into primary and scatter
contributions. Scatter dose includes dose that can be traced back to scattered photons
from Compton events as well as photons created through relaxation processes following
photoelectric and Compton events. Figure 3.6 displays the dose deposited in the water
and PMMA phantoms separated into the primary and scatter dose components.
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Figure 3.6 Separation of the primary and scatter dose components in water and PMMA
phantoms as a function of distance from the centre of the ‘Classic’ source.

From Figure 3.6, it is evident that close to the source the dose is predominantly due to
primary photons, while at distances larger than 6 cm the scatter contribution is larger than
that of the primaries. As expected, the scatter contribution is greater in the denser
PMMA material when compared with water.

3.3.2 FLURZnrc
The results from the DOSRZ simulations indicate a strong presence of scattered photons
especially at distances further away from the source. The FLURZnrc user code was
employed as a tool to further examine the 192Ir photon spectrum and how it changes with
distance from the source in water, air and PMMA. Using the same model of the ‘Classic’
source and a cylindrical phantom identical to the one used in the DOSRZnrc user code,
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the photon fluence was scored in 5 keV energy bins at distances along the transverse
source axis of 1 cm, 5 cm, and 10 cm from the source centre. A portion of the primary
photons emitted from the

192

Ir source core are attenuated and scattered by the source

encapsulating material as well as the core itself.

This leads to a modified photon

spectrum immediately outside the source that differs to the raw

192

Ir spectrum listed in

Table 3.1. The Monte Carlo spectra calculated in air for the ‘Classic’ source at a distance
of 5 cm is shown below in Figure 3.7:

Fluence/(MeV) / Source Particle / cm2
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Figure 3.7 Photon spectra for 192Ir ‘Classic’ source in air at a distance of 5 cm from the centre of
the source.

The fluence in each scoring region, differential in energy (i.e. fluence / MeV), is
calculated as the total path length in a given energy bin divided by the volume of the
scoring region per initial source particle.

This has been previously shown to be

equivalent to the fluence averaged over the volume of the scoring region (Rodgers et al.
2005).
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From the Monte Carlo simulated fluence spectra, the air kerma strength per unit activity
(SK /A) can be estimated at each of the chosen scoring distances. The air kerma strength
(SK) is a measure of the brachytherapy source strength. It is defined as the product of the


air kerma rate at a calibration distance d, ( K air (d ) ), measured along the transverse axis
of the source, and the square of the distance, d:


S k  K air (d )  d 2

[ µGy m2 h-1 ]

(3.1)

Borg & Rodgers (1999) outlined a method for determining the air kerma rate from the
FLURZ data output for each scoring region at 1, 5 and 10 cm from the source. This
method is demonstrated below:
The total air kerma in Gray (Gy) is related to the photon fluence by the expression:

K air  1.602  10

10

E max



E min

  en ( E ) 
  dE




 ( E )  E  

(3.2)

where  (E ) is the photon fluence per unit energy at each energy E (MeV) and µen(E)/ρ is
the mass energy absorption coefficient at energy E. The factor 1.602x10-10 is used to
convert Kair from MeV.g-1 into Gy, while the mass energy absorption co-efficient µen(E)/ρ
in air is taken to be the value corresponding to the energy E at the middle of each bin. As
mentioned above, FLURZ calculates the differential fluence spectrum φ’(E) per initial
photon, and so the air kerma per initial photon (K’air) is given by the equation:

K 'air  1.602  10

10

Emax

  en ( Ei ) 
  E




  ' ( E )  E  
i

Emin

i

(3.3)

where Ei is the midpoint of each energy bin and ΔE is the bin size. Therefore the air


kerma rate K air in (Gy s-1) for a 192Ir source of activity A (Bq) is given by:
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K air  K ' air  N photon


K air  K ' air 2.363  A

[Gy s-1]

(3.4)

where the number of photons Nphoton emitted per second is equal to the product of the
number of photons emitted per decay of

192

Ir (2.363 photons per decay) and the activity

A of the source (decays per second).
The air kerma strength per unit source activity is then calculated as the quotient of
Equation 3.1 and activity A:


S k K air ( d )  d 2

A
A
Sk
 2.363  K ' air ( d )  d 2
A

[Gy m2 s-1 Bq-1] (3.5)

The unit of Sk is usually denoted by the symbol U where:
1 U = 1 µGy m2 h-1
and so Equation 3.5 becomes:

Sk
 3.6  10 9  2.363  K ' air (d )  d 2
A

[U Bq-1]

Using the fluence spectra data scored along the transverse axis of the

(3.6)

192

Ir ‘Classic’

source in air, the air kerma strength per unit activity was calculated from Equation 3.6
above at distances of 1, 5 and 10 cm from the source. The results are shown in Table 3.3.
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Table 3.3

Comparison of air kerma strength per unit activity for the ‘Classic’ source as
calculated by various authors.

Distance from

This work

Borg (1999)

Buermann (1994)

Source Centre

Sk / A

Sk / A

Sk / A

(cm)

10-8 U Bq-1

10-8 U Bq-1

10-8 U Bq-1

1cm

9.59 ± 0.01*

-

-

5cm

9.77 ± 0.01*

-

-

10cm

9.75 ± 0.02*

-

-

Mean

9.76 ± 0.02*

9.79 ± 0.02

9.8 ± 1.5%

At distances less than or equal to 1 cm from the source the air kerma strength is lower
when compared to the Sk / A calculated at 5 cm and 10 cm. This is explained by the fact
that the source is not a point but has the finite geometry of a line source with the
radioactive

192

Ir distributed throughout the length of the source. At the surface of the

source capsule and within the first centimetre, some of the fluence originating from the
tips of the source does not reach the scoring region. In the TG-43 protocol, the geometric
factor G(r,θ) accounts for this variation due to the line shaped nature of the source. The
mean air kerma strength is consequently calculated as the average of Sk / A determined at
the distances of 5 and 10 cm from the source only. The average air kerma strength,

Sk / A, calculated from the fluence data in this work was 9.76 x 10-8 U Bq-1. Note that the
uncertainty is taken to be one standard deviation of the statistical uncertainty in the
fluence data.
This value for Sk / A was benchmarked against other published data by Borg & Rodgers
(1999) and Buermann et al. (1994), in which they determined an Sk / A value of
9.79 x 10-8 and 9.8 x 10-8 U Bq-1 respectively for the same ‘Classic’ source. The slightly
lower value calculated in this study is attributed to the exclusion of the bremsstrahlung
photons generated by the β- decays within the high Z Ir / Pt core. Borg & Rodgers (1999)
found the contribution of these bremsstrahlung photons to increase the air kerma strength
by 0.2% for the ‘Classic’ source. Taking the contribution of bremsstrahlung photons into
account as calculated by Borg & Rodgers (1999), the value of air kerma strength per
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activity for the ‘Classic’ source would become 9.78 x 10-8 U Bq-1. This value obtained
for the ‘Classic’ source modelled in this work was found to be in good agreement with
previously published data for the same source.

Following on from the measurements in air, the fluence was scored at identical distances
along the transverse axis of the source in a water phantom of radius 30 cm. Figures 3.8,
3.9 and 3.10 plot the photon fluence distribution (%) at 1, 5 and 10 cm from the source
respectively.
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Figure 3.8 Photon energy spectra in water at a distance of 1 cm from the centre of the ‘Classic’
source.
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Figure 3.9 Photon energy spectra in water at a distance of 5 cm from the centre of the ‘Classic’
source.
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Figure 3.10 Photon energy spectra in water at a distance of 10 cm from the centre of the ‘Classic’
source.

As was evident with the

192

Ir spectra in air shown in Figure 3.7,

192

Ir has a complex

spectrum with many energy peaks. At 1 cm from the source in water, the major peaks at
energies of 316 keV and 468 keV dominate the energy spectrum making up
approximately 27% and 17% of the photon fluence respectively. However, at depths of 5
and 10 cm in the phantom there is a noticeable increase in the portion of low energy
photons making up the spectrum.

The majority of these low energy photons are

secondary photons having undergone scattering in the phantom. The increased portion of
scattered photons present in the spectrum at 5 and 10 cm is consistent with the increasing
scatter component with depth shown in Figure 3.6. Plotting all three depths on the one
scale, as shown in Figure 3.11, there is a clear shift in the photon spectra toward lower
energies at large distances.
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Figure 3.11 Comparison of photon energy spectra in water at 1, 5 and 10 cm from the centre of
the ‘Classic’ source.

Meli et al. (1988) used their photon fluence data obtained by Monte Carlo simulation to
calculate the average energy of the spectrum at each depth of measurement. Adopting a
similar methodology, the average energy of the spectrum Eav was calculated from the
FLURZ data using the expression:

E av   P ( E i )E i

(3.7)

i

where P(Ei) is equal to the photon fluence Ф(Ei) at energy Ei divided by the total photon
fluence Ф in the spectrum, i.e. P(Ei) = Ф(Ei) / Ф. Table 3.4 shows the calculated average
photon energy in the 192Ir spectrum at 1, 5, 8 and 10 cm in water and PMMA.
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Table 3.4

Calculated average photon energy in water at 1, 5, 8 and 10 cm from the centre of the
‘Classic’ source. Data published by Meli et al. (1988) and Meigooni et al. (1988) is
provided for comparison.

Eav (keV)
Material / Distance

at 1 cm

at 5 cm

at 8 cm

at 10 cm

Water

323

234

199

187

Water (Meli / Meigooni)

337

258

-

221

PMMA

318

217

182

166

PMMA (Meli)

330

242

-

202

The calculated average photon energy at each depth shows a rapid decrease with distance
in each phantom.

The average photon energy in the water phantom changes from

323 keV at 1 cm to 234 and 187 keV at 5 and 10 cm respectively, representing a
degradation of 28% at 5 cm and 42% at 10 cm from the average energy at 1 cm. At the
calibration distance of 8 cm employed by the PTW cylindrical jig, the average photon
energy was determined to be 199 keV and 182 keV for water and PMMA respectively.
The lower average photon energy in the PMMA phantom is due to the greater density of
PMMA resulting in increased attenuation of the primary radiation as well as an increased
lower energy scatter contribution for the same depth in water.
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3.4

Discussion

The DOSRZ results presented in Figure 3.5 comparing the depth dose curves for water,
PMMA and silicon demonstrate the dependence of the photoelectric effect on the atomic
number Z at large distances from the source. From observation of the plotted data, as the
scoring region was moved further away from the transverse axis of the source, a greater
dose was deposited in the higher Z silicon voxel compared with the dose in water and
PMMA at the same point. At larger distances from the source there is an observed
increase in the number of lower energy photons in the spectrum as demonstrated by the
spectral data obtained in FLURZ. This increase in low energy photons in the spectrum
reflects the increase in the portion of scattered photons that are present at depths of 5 cm
and 10cm in the phantom.

This observation is also consistent with the increasing

proportion of scattered photons with depth shown in Figure 3.6, when the primary and
scatter photon components are separated. The presence of these low energy photons also
contributes to the increased likelihood of photoelectric interactions occurring in the
higher Z silicon material.
The Monte Carlo simulations ran in the FLURZ user code for the modelled
microSelectron ‘Classic’

192

Ir source served a number of purposes. Firstly, using the

method demonstrated by Borg & Rodgers (1999), the air kerma strength per unit activity
(Sk / A) was calculated from the photon fluence spectra in air. The Sk / A value of
9.76 x 10-8 U Bq-1 calculated for the ‘Classic’ source (without bremsstrahlung) was found
to be in good agreement with previously published data for the same

192

Ir source model.

This, along with the good agreement found between the DOSRZ data and that published
by Williamson & Li (1995), provided great confidence that the source had been modelled
correctly for the purposes of simulating dose and photon spectra along the transverse axis
of the source. Secondly, FLURZ was used to score photon fluence in water and PMMA
phantoms and examine how the

192

Ir spectrum changes with depth in these materials.

From the spectra plotted at 1, 5 and 10 cm in Figures 3.8, 3.9 and 3.10 respectively, a
clear shift toward lower photon energies was observed at larger distances from the source
in both phantoms. As displayed in Table 3.4, this shift was also observed in the work
published by Meigooni et al. (1988) and Meli et al. (1988) for a similar
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192

Ir spectrum,

with their average photon energy values matching relatively well with those calculated in
this study. The slightly higher average photon energies calculated by Meli and Meigooni
at distances of 1, 5, and 10 cm from the source (Table 3.4) reflect their use of larger
energy bins (20 keV compared with 5 keV) resulting in a small binning artifact.
Simulations in DOSRZ and FLURZ were also performed with a 0.5 mm stainless steel
applicator placed immediately outside the source capsule to mirror the applicator used in
the PTW jig set-up described in the next chapter. In both cases, the presence of the
applicator had a negligible effect on the dose and fluence scored in each phantom
environment.
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3.5

Conclusion

The EGSnrc Monte Carlo code has been effectively used to model the microSelectron
‘Classic’

192

Ir HDR brachytherapy source. The depth dose characteristics along the

transverse axis and the calculated air kerma strength per unit activity (Sk / A) of the
modelled source was shown to closely match other published data for this source. The
geometry of the source was modelled to be equivalent to the

192

Ir HDR brachytherapy

source used at The Canberra Hospital. The real source was later employed for the
characterisation of the PTW diode probes and MOSkinTM in Chapter 4.
The DOSRZnrc and FLURZnrc modules simulated dose deposition and photon fluence
respectively in a water and PMMA cylindrical phantom. The dose distribution scored in
water, PMMA and silicon voxels along the transverse axis of the source were presented
for distances ranging from 0.5 to 25 cm from the source. While the dose deposited at
large distances from the source is of little concern in brachytherapy, it highlighted the
discrepancy between the dose scored in silicon and water as the

192

Ir spectrum softens

with depth. The photon fluence spectra displayed at 1, 5 and 10 cm in water qualitatively
and quantitatively showed this change in spectrum as a function of distance from the
source. These data emphasised the increased prevalence of low energy scattered photons
that contribute to the dose at depth in water. This spectral softening at depth was well
noted for the measurements and calibration of the diode probes and MOSkinTM in
Chapter 4.
The use of Monte Carlo in this work provided a greater understanding of photon
interactions, photon energies, the effects of the phantom media and how all these entities
can affect dose deposition around an

192

Ir source. The results presented in this chapter

brought to note a number of effects to be considered during phantom measurements with
the diode probes and MOSkinTM. The main effect observed was the change in energy
response of the silicon detectors with the lower energy photons present at large distances
from the source. The difference in the depth dose curves for the silicon voxel and water
suggested that it is more appropriate to calibrate the dosimeters at distances closer to the
source where the curves show a better agreement in energy response. It also raised the
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question whether the method proposed for calibration at 8 cm in the PTW cylindrical jig
would yield an accurate calibration factor. This issue is the subject of investigation in
Chapter 5.
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Chapter 4:
Characterisation of the PTW Diode Probes
and MOSkinTM for in vivo Dosimetry in High
Dose Rate Brachytherapy
4.1

Introduction

In vivo dosimetry is the most direct method of monitoring the dose delivered to the
patient receiving radiotherapy. It can provide a safeguard against major set-up errors as
well as calculation or transcription errors that may have been missed in a pre-treatment
check. Even in the absence of errors, it can also provide quantitative information on the
dose delivered to regions of interest and critical organs. In vivo dosimetry is especially
useful in high dose rate (HDR) gynaecological brachytherapy due to the high doses
delivered in the immediate vicinity of the source and the close proximity of the rectum
and bladder to the implant.
Before commencing an in vivo dosimetry program, a clear understanding of the
capabilities and limitations of the system is imperative to achieve meaningful results.
Each system is unique and so a broad knowledge of how the dosimeter will behave under
certain conditions must be known before the dosimeter can be used clinically. Some of
the dosimeter characteristics to examine include dose and dose-rate effects, angular and
temperature dependence, effects of irradiation history and annealing, linearity in
measurement, and the response of the dosimeter to different energy ranges and types of
radiation. Other physical properties of the dosimeter including detector size and any
packaging or encapsulation can also influence how the dosimeter responds to radiation.
Examining all these characteristics involved preliminary experimentation and analysis for
each dosimetry system, the results of which make up the content in this chapter.
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The two in vivo dosimetry systems used in this study are the PTW Afterloading
Semiconductor Probe system and the Centre for Medical Radiation Physics (CMRP)
MOSkinTM with the associated Clinical Semiconductor Dosimetry System (CSDS). Both
these systems are presented in more detail in the sections below. The semiconductor
probes and MOSkinTM were characterised in terms of energy response, linearity, angular
dependence, temperature dependence and reproducibility for use with an

192

Ir HDR

brachytherapy source. These characteristics were used to assess the accuracy of each
dosimetry system for measuring rectum and bladder dose during HDR gynaecological
procedures, as well as to highlight any limitations that may affect the measurement.

4.2

Materials and Methods

4.2.1 PTW Semiconductor Probes
The PTW semiconductor probes are designed for intracavity in vivo dosimetry in the
rectum and bladder during HDR brachytherapy.

The rectum probe (T9112) has a

diameter of 7 mm and consists of an array of five diodes surrounded by a rubber
encapsulation as shown in Figure 4.1. The diodes are spaced 15 mm apart so that the
dose over a whole section of the rectum can be measured, minimising the chance of
missing any hotspot where the maximum dose is delivered.

Figure 4.1 Schematic diagram of the PTW rectum diode probe array with five individual diodes
capable of simultaneous dose readout (PTW 2003).
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The bladder probe (T9113) is much smaller than the rectum probe having a diameter of
only 3 mm allowing it to be inserted up through the urethral catheter and into the bladder.
The bladder probe consists of a single diode only as shown below in Figure 4.2.

Figure 4.2 Schematic diagram of the PTW bladder diode probe (PTW 2003).

The charge collected in each diode as a result of exposure to ionising radiation was
measured on the VIVODOS dosemeter via a detector connection box located in the
treatment room. The VIVODOS dosemeter allows simultaneous measurement in 12
channels allowing the bladder and rectum probes to be readout at the same time during
treatment. The VIVODOS screen can display either the absolute maximum of the five
diode array and bladder probe or the reading in multiple channels simultaneously. The
information displayed is provided in real-time.

Figure 4.3 Photo of the PTW VIVODOS electrometer for the readout of the rectum and bladder
diode probes.
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4.2.2 MOSkinTM and Clinical Semiconductor Dosimetry System
The MOSkinTM is a patented metal oxide semiconductor field effect transistor (MOSFET)
that has been designed and developed at the Centre of Medical Radiation Physics at the
University of Wollongong for in vivo dosimetry. This unique design incorporates a
single MOSFET sensor mounted on a silica backing board and wrapped in a thin layer of
heat shrink packaging. A major advantage of the MOSkinTM design is its extremely thin
build-up layer that allows measurement of skin dose at a depth of 0.07 mm. This depth
corresponds to the basal cell layer of the skin and is the recommended depth of reporting
skin dose as outlined by the International Commission on Radiological Protection,
Publication 59 (ICRP 1991). Other commercially available MOSFET designs have an
epoxy bubble encapsulation around the sensor that can cause artificial build-up and thus
alter the effective point of measurement for the device.

Furthermore, this epoxy

encapsulation is often not distributed uniformly over the sensor leading to differences in
angular response.
The physical dimensions of the entire MOSkinTM, including backing board and packing,
are approximately 3 mm x 3 mm, with a thickness of 2 mm. The MOSFET detector chip
itself has dimensions of 0.8 mm x 0.6 mm with a thickness of 0.4 mm, while the sensitive
silicon oxide gate has a thickness of 0.55 µm. The small dimensions of the sensitive
region make the MOSkinTM a high spatial resolution device, ideal for use in
brachytherapy.

Build-up layer
~ 0.8 mm

Figure 4.4 Drawing of a commercial MOSFET with an epoxy bubble enclosing the MOSFET
sensor (left); and the MOSkinTM with its thin build-up layer (right).

The MOSkinTM detector functions by applying a +5 V bias voltage across the gate. When
exposed to ionising radiation a negative shift in the threshold voltage ΔVTH occurs, which
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is proportional to the energy deposited in the silicon substrate. This shift in threshold
voltage ΔVTH was measured and displayed on the Clinical Semiconductor Dosimetry
System (CSDS), designed and built by the Centre for Medical Radiation Physics,
University of Wollongong. This system also supplies the gate voltage to the MOSkinTM
and has five channels for simultaneous dose readout.

Figure 4.5 Clinical Semiconductor Dosimetry System (CSDS) with MOSkinTM attached for
readout of the MOSkinTM threshold voltage VTH.

4.2.3 NE2571 Farmer Chamber and PTW UNIDOS Electrometer
The reference dosimeter to which the diode probes and MOSkinTM were calibrated against
was a 0.6 cc NE2571 Farmer ionisation chamber, used in combination with a PTW
UNIDOS electrometer. This chamber and electrometer combination is traceable to the
Australian Radiation Protection And Nuclear Safety Agency (ARPANSA) primary
standards laboratory, in which an air kerma calibration factor (NK) had been measured.
The ionisation chamber is a cylindrical chamber with a thin walled graphite thimble and a
central aluminium electrode defining the sensitive volume.
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The dimensions of the

sensitive volume are approximately 24 mm in length and 6 mm in width, giving a total
sensitive volume of 0.69 cm3 (Nuclear Enterprises 1980).

The PTW UNIDOS

electrometer has a number of different operating modes and is capable of measuring
charge, nominal dose or current. It was used in the ‘high’ dose range and at its nominal
operating voltage of -300 V.

4.2.4 PTW Calibration Phantom
The PTW probes were supplemented with a cylindrical PMMA jig designed for
calibrating the rectum and bladder diode probes (Figure 4.6). A photo of the cylindrical
jig with the dosimeters housed inside is shown in Figure 4.6 on top of 9 cm of perspex
slabs used to elevate the jig off the table. The calibration jig has a diameter of 20 cm, a
height of 12 cm and contains four holes spaced equidistant from the centre of the
phantom at a distance of 8 cm. Each of the detectors including the 0.6 cc NE2571 Farmer
ionisation chamber are positioned in one of these peripheral holes so that all detectors lay
at an equal distance of 8 cm from the source. A fifth central hole houses a thin stainless
steel applicator allowing the source to be driven into the centre of the PMMA jig. The
concept of the calibration jig is that the probes can be simultaneously irradiated with an
ionisation chamber traceable to a standards laboratory so that a calibration factor is
obtained for each detector allowing conversion of dosimeter readings into dose.

71

Figure 4.6 Photo of the PTW PMMA cylindrical calibration jig with the rectum probe,
MOSkinTM and ionisation chamber all positioned at 8 cm from the central source
applicator.

To ensure that the position of the diode probes, MOSkinTM and ionisation chamber were
reproducible, PMMA plugs were custom made to fit each of the dosimeters. These plugs
are shown in Figure 4.7. The plugs are machined precisely so that the detectors sit
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snuggly inside the plug with minimal air gap and the plugs themselves slot neatly into the
holes positioned at 8 cm in the phantom. Two concentric PMMA cylinders are used to
hold the source applicator in place. The narrower of the two cylinders houses the thin
stainless steel applicator while the outer cylinder ensures the source and applicator are
positioned to line up with the centre of each dosimeter. As mentioned above, these plugs
come custom made for the PTW probes so in order to house the MOSkinTM in one of
these plugs, the MOSkinTM packaging was altered to mirror the design of the PTW
bladder probe. The thickness of the cable was produced to be approximately 3 mm and
the MOSFET sensor placed 8 mm from the end of the probe so that the sensitive volume
would be precisely at the same distance from the source as the other dosimeters.

Figure 4.7 Photo of the PMMA plugs for housing each dosimeter and the source applicator. The
plugs are then inserted into the calibration jig with the dosimeters placed equidistant
from the central source at a distance of 8 cm.
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The reason for housing these detectors in custom made plugs is two fold. As shown in
Figures 4.6 and 4.7, they provide a reproducible set-up in the calibration jig.
Furthermore, the depth in which each detector is placed in their individual plug is
designed specifically so that the centre of the sensitive volume is exactly 8 cm and
parallel to the centre of the 192Ir ‘Classic’ source when driven out to the end of the source
applicator. In the case of the five diode rectum array, the plug positions the probe so that
the central diode in the array is in line with the centre of the source, as shown in Figure
4.8. When calculating calibration factors for the surrounding diodes in the rectum array,
the PTW software program MultiCalTM corrects for the different distances of each diode
from the location of the source.

Figure 4.8 Schematic diagram of the rectum diode array and ionisation chamber inside the
cylindrical PMMA calibration jig. With each dosimeter housed in their respective
plugs, the central diode in the array and the centre of the ionisation chamber sensitive
volume are aligned parallel to the centre of the ‘Classic’ source.
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4.2.5 Investigation into the Energy Response of the PTW Diode
Probes and MOSkinTM
The method described in the previous section for calibrating the detectors in the
cylindrical jig set-up against an ionisation chamber had some flaws that needed to be
considered if accurate dosimetry was to be achieved. Firstly, the calibration jig itself
does not provide full scattering conditions in all directions surrounding each detector. A
more significant issue was the distance from the source at which the diode probes and
MOSkinTM were calibrated at. While calibrating the dosimeters in the jig at 8 cm avoids
the steep dose gradient present close to the

192

Ir source, a distance of 8 cm is not of

clinical relevance in brachytherapy. What’s more, the organs at risk, such as the rectum
and bladder, generally lie within a few centimetres of the source. By calibrating at 8 cm
it is also assumed that the sensitivity and response of each detector remained the same
whether positioned close to the source or at 8 cm. While this is a reasonable assumption
for ionisation chambers, which are generally considered to be energy independent, it has
been shown not to be the case for silicon detectors such as diodes and MOSFETs that
have a known energy dependence at low energies below 100 keV (Edwards et al. 1997;
Kron et al. 1998). This energy dependence was also demonstrated in Chapter 3, where a
difference in dose scored in the silicon voxels was observed with respect to that scored in
water. This difference became more pronounced as distance from the source increased
due to the predominant low energy photon contingent in the spectrum.

75

Figure 4.9 Energy response of TLDs, diodes and MOSFETs at low photon energies
(Edwards et al. 1997).

From the Monte Carlo results shown in the previous chapter, it was found that the
average energy in the photon spectrum changed from 318 keV at 1 cm from the source to
182 keV at 8 cm in PMMA with an observable shift in the fluence distribution towards
the lower energy end of the spectrum. Also observed was the increase in the number of
low energy photons present at greater depths in the phantom that could potentially have
an influence on the response of the diodes and MOSkinTM when calibrated at 8 cm in the
calibration jig.

4.2.5.1 Calibration and Energy Response in an

192

Ir High Dose

Rate Brachytherapy Source
The set-up of the ionisation chamber, diode probes and MOSkinTM in the calibration jig
was described in Section 4.2.4 and shown in Figure 4.6, with each of the detectors placed
at 8 cm from the source. To obtain the calibration factor (CF) for the diode probes and
MOSkinTM a relation between dosimeter reading and dose was required. To determine
this relationship the dosimeters were simultaneously irradiated for a designated time
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period in the calibration jig with the ionisation chamber. The source was driven out of
the afterloading unit and into a stainless steel applicator via a transfer tube. The dwell
position was located at a distance of 995 mm from the indexer, which corresponds to the
end of the source applicator. This dwell position also meant that the centre of the source
was perpendicular to the centre of the diodes and MOSkinTM.
The calibration factor (CF) was calculated as the quotient of the reading on the diode or
MOSkinTM (MDiode or MMOSkin) and the reading on the ionisation chamber (Mion), once the
appropriate correction factors have been applied. The terms on the denominator of
Equation 4.1 are used to calculate the dose measured by the ionisation chamber at the
corresponding point in the phantom. This expression on the denominator is adopted from
the International Atomic Energy Agency report TRS-277 “Absorbed Dose Determination

in Photon and Electron Beams” (IAEA 1997), more specifically the section on measuring
dose to water in medium energy x-ray beams.

M Diode

CF 

water

 
M ion  N K  kTP  kelec  ku   en 
 pu
   air

[reading cGy-1] (4.1)

The terms in the above expression are described below. Values for NK and kelec are taken
from the calibration reports for the ionisation chamber and electrometer respectively
issued by the ARPANSA primary standards laboratory (ARPANSA 2007a, 2007b).

NK

-

Air kerma calibration factor for ionisation chamber determined at ARPANSA
standards laboratory. Interpolated between NK for 164 keV and

60

Co for an

energy of 397 keV. The value of NK was determined to be 41.67 mGy nC-1
(ARPANSA 2007a).
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kTP

-

Factor to correct ionisation chamber reading Mion for temperature and
pressure.

This correction was determined to be 1.078 on the day of

measurement.

kelec -

Calibration factor for UNIDOS electrometer determined at ARPANSA
standards laboratory.

The value of this factor is 0.01997 nC rdg-1

(ARPANSA 2007b).

ku

-

Factor to account for variations in spectral distribution of x-rays used for the
calibration of the ionisation chamber free in air and that present in the user
set-up in water. According to TRS-277 (IAEA 1997) this can be taken as
unity for the ionisation chamber used in this work.

pu

-

Perturbation factor correcting for the replacement of water by the ionisation
chamber air volume. According to Table XV in TRS-277 (IAEA 1997), this
value is approximately unity for a standard thimble ionisation chamber.

  en

 

water



- Ratio of mass-energy absorption coefficients of water and air at 182 keV;
 air
This ratio was determined to be 1.109.

While the TRS-277 protocol defines medium energy x-ray beams to range between 100
and 300 keV, it was chosen to be the most appropriate for measuring dose in water for the
192

Ir spectrum in this work. An alternative was to follow the formalism outlined in the

International Atomic Energy Agency report TRS-398 (IAEA 2000), which is employed
60

in section 4.2.5.2, using the dose to water factor ND,w given for
However, since the

60

Co beam is more energetic than that of the

ARPANSA supplying air kerma factors (NK) for 164 keV and

Co by ARPANSA.

192

Ir source and with

60

Co for the ionisation

chamber, it appeared more appropriate to follow the TRS-277 air-kerma based protocol
with an interpolated value of NK. As mentioned above, the air kerma factor NK was
interpolated to give a value at an energy of 397 keV, the average weighted energy of an
192

Ir source according to TEC-DOC-1274 (IAEA 2002). Fortunately, this NK factor varies
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quite slowly for the NE2571 Farmer chamber between 164 keV and 60Co (approximately
0.3%) and is therefore relatively energy independent.
The ratio of mass energy absorption coefficients,  en /  air , was determined to be
water

1.109 at an energy of 182 keV, which related to the average weighted photon energy
present at 8 cm in the PMMA cylindrical phantom according to the Monte Carlo data in
Table 3.4, Chapter 3. This value was calculated by interpolation of the mass-energy
absorption coefficient (µen/ρ) data for water and air respectively, obtained online at the
National Institute of Standards and Technology (NIST) website. The NIST database of
mass-energy absorption coefficients is based on data calculated by Hubbell & Seltzer
(2004) and the values for a subset of energies are shown in Table 4.1 below.

Table 4.1

Tabulated data of mass-energy absorption coefficients (µen/ρ) for water and air taken
from the NIST database (Hubbell & Seltzer 2004).

Energy (keV)

 en /  water

 en /  air

water
 en /  air

150

2.762 x 10-2

2.496 x 10-2

1.107

182

2.894 x 10-2

2.609 x 10-2

1.109

200

2.967 x 10-2

2.672 x 10-2

1.110

Onserving the curves in Figure 4.10, it is clear that the values for mass-energy
coefficients are reasonably constant above 100 keV, but change rapidly at lower energies
below 100 keV. The values for  en /  air

water

presented in Table 4.1 are also in agreement

with those published by Reynaert, Verhaegen & Thierens (1998) shown in Table 4.4.
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Figure 4.10 Graphs of mass-energy absorption coefficients (µen/ρ) for a) water and b) air taken
from the NIST database (Hubbell & Seltzer 2004).
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4.2.5.2 Calibration and Energy Response in a 6 MV Linear
Accelerator Beam
The initial investigation into energy response was to compare the calibration factor of the
diodes and MOSkinTM as determined in a Varian 2100C/D 6 MV linear accelerator beam
with the calibration factor previously obtained in the calibration jig with the 192Ir source.
A perspex block phantom was constructed out of 200 x 200 mm2 individual slabs of
various thicknesses ranging from 1.5 to 50 mm. A hole was drilled in one of the slabs
(shown in Figure 4.11) to house the PTW PMMA plugs so that the ionisation chamber,
rectum probe, bladder probe and MOSkinTM could all be irradiated individually knowing
that their positioning in the phantom was identical.

Figure 4.11 Schematic diagram of perspex slab to house the PTW diode probes and MOSkinTM in
their respective plugs.

The set-up under the linac beam involved 5 cm of perspex slabs on top for build-up at an
SSD of 95 cm with each detector individually placed at 5 cm depth for their respective
irradiation (Figure 4.12). Sufficient backscatter material was also placed underneath the
slab housing the detector. A field size of 10 x 10 cm2 was used with the centre of the
field corresponding to the centre of the sensitive volume of the ionisation chamber, diode
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or MOSkinTM respectively. For the rectum probe the centre of the field was aligned with
the middle diode in the array. A dose of 100 monitor units (MU) was delivered at a dose
rate of 600 MU min-1.

For this set-up 1 MU = 1 cGy under reference conditions,

corresponding to a dose of approximately 1 Gy delivered to each detector.

Figure 4.12 Perspex Slab set-up under the Varian 2100C/D linear accelerator for the calibration
of the diode probes and MOSkinTM in a megavoltage photon beam.

The calibration factor for the diodes and MOSkinTM was calculated using a slightly
different expression to Equation 4.1. For the dose measured by the ionisation chamber
(expressed on the denominator), the formalism used in this case was taken from the IAEA
TRS-398 protocol (IAEA 2000) for the calculation of dose to water for high energy
photon beams. The ND,w,Qo term is an absorbed dose to water calibration factor for the
ionisation chamber at the

60

Co reference beam quality at ARPANSA. This ND,w,Qo was

taken from the calibration certificate issued by ARPANSA for the calibration of the
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secondary standard ionisation chamber (ARPANSA 2007a) and has a value of
45.47 mGy nC-1. The other correction factor kQQo is used to correct for the slight change
in response of the same ionisation chamber in a 6 MV photon beam compared to the 60Co
source at the standards laboratory. The value of kQQo was taken from Table 14 in the
TRS-398 protocol (IAEA 2002) and determined to be 0.9935 for the 6 MV beam quality
of the Varian 2100C/D linear accelerator. The calibration method based on TRS-398 is
shown below in Equation 4.2.

CF 

M Diode
M Ion  kTP  kelec  N D ,w,Q0  kQ ,Q0

[reading cGy-1]

(4.2)

4.2.5.3 Relative Energy Response at Varying Distances from an
192

Ir source

The second part of the energy response measurements involved looking into how the
response of the diodes and MOSkinTM changed relative to the ionisation chamber with
distance from the

192

Ir source considering the change in the average spectral energy

demonstrated in the previous chapter.

The same slab phantom used in the linear

accelerator calibration was used for these measurements as well. Another hole was
drilled in one of the slabs to house the source applicator and plug. A photo of the set-up
is shown in Figure 4.13.
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Figure 4.13 Slab set-up for measuring dosimeter response at various distances from the

192

Ir

‘Classic’ source.

Using the slab configuration limited the closest separation achievable between the centre
of the source and centre of each detector to 2.3 cm, due to the widths of the slabs and
plugs. Keeping the source applicator in a fixed position, the slab housing the dosimeter
was gradually moved perpendicularly away from the source by placing additional slabs
in-between the source and dosimeter. Source to dosimeter distances ranged from 2.3 cm
out to 8 cm. An additional 9 cm of perspex was placed underneath the slab containing
the source, while approximately 12 cm backscatter was maintained behind the dosimeter
at each measuring point to obtain full scatter.
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The initial measurement involved aligning the centre of the source to the centre of the
sensitive volume of the ionisation chamber so that they were perpendicular to each other.
To determine this position the source was stepped in 2.5 mm increments through the
source applicator to find where the largest reading occurred. The highest reading was
found when driving the source out to a distance of 995 mm from the indexer. This source
position was maintained for the remainder of the measurements in the slab phantom.
Individual sets of measurements were performed for the PTW rectum and bladder diode
probes, the MOSkinTM, and ionisation chamber at each of the selected distances from the
source. Irradiation times were varied according to the distance of each dosimeter from
the source as well as the strength of the source on the day of measurement. All readings
were normalised for dwell time and source activity. For the MOSkinTM, a threshold
voltage shift of at least 50 mV was strived for to ensure that a significant reading with
negligible uncertainty was obtained.

4.2.6 Linearity and Reproducibility
Using the same slab set-up described in the previous section, the linearity of the diode
probes and MOSkinTM with irradiation time was investigated.

Each dosimeter was

individually placed at a distance of 8 cm from the source and irradiated for periods
ranging from 30 to 300 seconds.
The reproducibility of the diode probes and MOSkinTM was recorded on each day of
measurement. For long-term reproducibility, it was important to replicate the set-up
identically each time. For this reason, the first measurement of the day involved placing
the diode probes, MOSkinTM, and ionisation chamber in the cylindrical PMMA jig
(shown in Figure 4.6).

These readings were used to determine the long-term

reproducibility of the detectors over a six month period. The general practice for each
dosimeter was to take the average of two consecutive readings at each distance from the
source. Short-tem reproducibility was assessed on how consistent consecutive readings
were for each of the PTW diode probes and MOSkinTM.
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4.2.7 Angular Dependence
The angular dependence in the axial plane of the PTW rectum diode probe and
MOSkinTM was measured using the cylindrical PTW calibration jig as shown below in
Figure 4.14. The bladder probe was not included in these tests, but it is likely that the
angular response of the bladder diode is very similar to that of the diodes used in the
rectum probe as the diodes are of the same design. The importance of measuring this
characteristic for each dosimeter arises not only from the known angular dependence
published in the literature for these type of detectors, but the fact that there is no way of
knowing the orientation of the diode probes and MOSkinTM once they have been inserted
into the patient’s rectum and bladder.

Figure 4.14 Measurement of angular dependence of the diode probes and MOSkinTM in the PTW
PMMA cylindrical jig.
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For these measurements, the source was inserted into one of the holes on the outside of
the jig while the plug to house each dosimeter was placed in the middle of the phantom.
Each dosimeter was rotated along its axis through a full 360º revolution by turning the
plug and ensuring that the dosimeter remained in a fixed position. A polar plot marking
each of the angles was stuck to the top of the jig and used as a guide for rotation. The
angular response of the MOSkinTM was measured every 30º starting at the top surface
containing the sensitive layer which was called the 0º position. Unlike the MOSkinTM,
the PTW rectum probe has no marking to indicate where the top of the diodes are and so
an arbitrary mark was placed on the probe which was then called the 0º position. Since
there was no way of knowing the orientation of the diodes in the rectum probe and due to
time restrictions on that particular day, angular response measurements were only taken
at angles of 0º, 45º, 90º, 180º and 270º.

4.2.8 Temperature Dependence
All the previous measurements described in the above sections were carried out at room
temperature. However, the intention is to use the diode probes and MOSkinTM clinically
to determine the dose measured in vivo to the patient’s rectum and bladder during
treatment. Therefore, it was necessarily to examine the response of the probes over a
range of temperatures to ensure that their characteristics measured in the perspex
phantoms are valid when placed inside a patient with a body temperature of
approximately 38º C.
The effect of temperature variations on the response of the PTW diode probes and
MOSkinTM was carried out on the same 6 MV beam used for the linear accelerator
calibration. The main reason for choosing to carry out these measurements in the 6 MV
beam as opposed to the brachytherapy source was due to the simplicity of set up and not
having to worry about fixing the position of the source in water. A perspex holder was
built to house the rectum probe, bladder probe and MOSkinTM side by side in a beaker of
water as shown in Figure 4.15. Thin perspex rods attached to the perspex provided a
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support to attach each of the probes to, ensuring movement inside the beaker of water
was minimal.

Figure 4.15 Perspex support to fix the diode probes and MOSkinTM inside water-filled beaker for
temperature dependence measurements.

Both of the diode probes and MOSkinTM were placed in waterproof sleeves, the same as
which are required for infection control. The temperature was controlled through a
heater-stirrer system with the beaker placed on top of the heating plate and the
thermometer feedback control placed inside the beaker of water (Figure 4.16). With the
diode probes, MOSkinTM and thermometer placed inside the beaker of water, the beaker
was then placed on top of the heating plate. This equipment was positioned on top of the
treatment couch and with the gantry at an angle of 90º, the light / x-ray field was
collimated to irradiate each of the probes in the beaker simultaneously.
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Figure 4.16 a) Schematic diagram of the set-up used for temperature dependence measurements
on the linear accelerator; b) Photo of the set-up on the linear accelerator couch.

The initial temperature of the water in the beaker was at tap temperature 23º C. The
water temperature was then gradually increased in increments set by the heater stirrer
system up to 40º C. At each temperature increment the probes were left to equilibrate for
5 minutes before delivering a dose of 50 MU and obtaining the subsequent dosimeter
readings.
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4.3

Results

4.3.1 Comparison of Dosimeter Energy Response in

192

Ir and a

6 MV Linear Accelerator Beam
As outlined in Sections 4.2.5.1 and 4.2.5.2, the diode probes and MOSkinTM were
calibrated against the local standard ionisation chamber both in the cylindrical jig under
the

192

Ir source and in a 6 MV linear accelerator beam respectively. This yielded a

calibration factor (CF) relating the charge collected in the diode probes (or shift in
threshold voltage in the case of the MOSkinTM) to dose in cGy for both the

192

Ir source

and 6 MV photon beam. These calibration factors for the diode probes and MOSkinTM
are displayed in Table 4.2 below. Note that for the rectum probe the calibration factor is
only valid for the central diode and a correction for distance must be applied to the four
other diodes in the array.

Table 4.2

Calibration factors (CF) for the diode probes and MOSkinTM in 192Ir and 6 MV linear
accelerator (linac) beam.

Dosimeter
Rectum Diode
(nC cGy-1)
Bladder Diode
(nC cGy-1)
MOSkinTM
(mV cGy-1)

CF in 192Ir source at

CF in 6 MV Photon

8 cm Jig Set-up

Beam on linac

23.52 ± 0.07

20.33 ± 0.06

15.7

23.95 ± 0.06

20.80 ± 0.05

15.1

2.80 ± 0.07

2.38 ± 0.02

17.6

% Difference btw
192

Ir and 6 MV

The calibration factor, CF, obtained in the jig set-up was found to be larger under the 192Ir
source when compared with the value measured on the linear accelerator beam . The
magnitude of this difference in CF is approximately 15% for both the rectum and bladder
diodes and 17.6% for the MOSkinTM.
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4.3.1.1 Relative Energy Response with Distance from

192

Ir

Source in Slab Phantom
Following the comparison of calibration factors for each dosimeter obtained for the jig
and linear accelerator set-ups respectively, further investigation was performed into the
variation in response of each dosimeter as a function of distance from the

192

Ir source.

This helped to fathom whether it was more accurate to calibrate the diode probes and
MOSkinTM closer to the source, where they would be clinically used, as opposed to the
PTW cylindrical jig distance of 8 cm.
As mentioned in the method, Section 4.2, Chapter 4, the rectum and bladder diode
probes, MOSkinTM and ionisation chamber were all individually placed in the perspex
slab phantom to measure relative dose at distances ranging from 2.3 to 8 cm from the 192Ir
source. Figure 4.17 shows the relative response of each dosimeter as a function of
distance from the source normalised to a distance of 8 cm. The error bars indicate the
uncertainty in measurement incorporating the uncertainty in the positioning of each
dosimeter from the source. The positioning error is based on an uncertainty of 0.5 mm in
the centering of each hole drilled in the two perspex slabs (Figure 4.11) to hold the plugs
for housing the dosimeters and source applicator respectively. It is clear from Figure
4.17 that the uncertainty in positioning has a larger effect on the measurement in the steep
dose gradient region at distances close to the source. The uncertainties are much smaller
further away from the source at the calibration point of 8 cm.
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Figure 4.17 Relative response of the rectum probe, bladder probe, MOSkinTM and ionisation
chamber as a function of distance from the 192Ir source when normalised at a distance
of 8 cm along the transverse axis of the source.

The most notable feature from Figure 4.17 is the separation between the relative response
of the ionisation chamber when compared with the diode probes and MOSkinTM, which
becomes more prominent as the chamber is moved closer to the source. There is good
agreement in the response of the two diode probes and MOSkinTM over the whole range
of measurement points. The data for these dosimeters all lie within approximately 5% of
each other with the maximum deviation occurring when the dosimeters are closest to the
source.

At the closest measurable distance of 2.3 cm, the difference between the

ionisation chamber response and the other dosimeters is lower by 12%, 9% and 7% for
the rectum probe, bladder probe and MOSkinTM respectively. This difference in response
of the ionisation chamber was attributed to a number of effects:
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i.

The effective point of measurement in the ionisation chamber is unknown.
Close to the source there will be a large dose gradient across the whole air
cavity and so the measured value is proportional to the average ionisation within
the chamber volume. In contrast, the diodes and the MOSkinTM both have a
high spatial resolution and are capable of measuring at a finite point within the
detector.

ii.

The displacement effect caused by replacing part of the solid ‘water equivalent’
phantom by a low-density air cavity.

iii.

The non-uniformity effect which is caused by the divergence of incident
photons on the chamber resulting in a non-uniform electron fluence inside the
chamber cavity.

Tolli & Johansson (1993a, 1993b) and Reynaert et al. (1998) described these ionisation
chamber effects in more detail and determined methods of correcting for them. The first
two effects (i. and ii.) are related to each other and are accounted for by a single
displacement correction factor pd defined as the ratio of air kerma averaged in an air
volume the size of the chamber cavity, in water and air respectively (Ma & Nahum 1995).

pd  K airw / K airair

(4.3)

The non-uniformity effect is corrected by a factor pn (Tolli) or pV (Reynaert) and is
strongly dependent on distance from the source as well as chamber cavity dimension.
Determining these two correction factors for the NE2571 ionisation chamber and
‘Classic’ source combination used in this work is beyond the scope of this project and
hence no corrections were applied for these effects. However, Tables 4.3a, 4.3b and 4.4
show the magnitude of these factors as measured by the mentioned authors above.
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Table 4.3a Tolli & Johansson (1993b) – Experimentally determined inverse non-uniformity
correction factors pn (rcyl) to correct for the non-uniformity effects in the vicinity of a
5.5 mm 192Ir source.

Table 4.3b Tolli & Johansson (1993b) – Displacement correction factors pd (rcyl) for ionisation
chambers of different radii in 60Co and 192Ir sources.

Table 4.4

Reynaert et al. (1998) – Correction factors for displacement effect pd and nonuniformity effect pV for NE2571 ionisation chamber in vicinity of GammamedTM PDR
192

Ir source.
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4.3.2 Linearity
The linearity in dosimeter response for irradiation times ranging from 30 to 300 seconds
were recorded for the PTW rectum and bladder probe and MOSkinTM. The results are
normalised to the reading recorded at 300 seconds for each dosimeter and plotted in
Figure 4.18.
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Figure 4.18 Plot of linearity in dosimeter response with irradiation time normalised for an
irradiation time of 300 seconds.

The points are fitted by linear regression giving a R2 value of 0.999 for all dosimeters
with a standard error of 0.021, 0.014 and 0.003 for the rectum probe, bladder probe and
MOSkinTM respectively.
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4.3.3 Reproducibility
The long-term reproducibility of the diode probes in the cylindrical calibration jig was
evaluated over the six-month period in which measurements were performed. The shortterm reproducibility was assessed on the variation in consecutive measurements on a dayto-day basis.

The reproducibility for each dosimeter is expressed in terms of the

maximum range in variation from the mean and the coefficient of variation (CV), which is
defined as the quotient of the standard deviation and the mean. The results are displayed
below in Table 4.5.

Table 4.5

Long-term and short-term reproducibility of each dosimeter and their respective
coefficients of variation.

Rectum Diode
Parameter
Reproducibility
‘Long-Term’
Reproducibility
‘Short-Term’

Bladder Diode

MOSkinTM

Range (%)

CV (%)

Range (%)

CV (%)

Range (%)

CV (%)

-4.9 to 5.2

± 3.3

-0.9 to 1.4

± 1.2

-4.4 to 4.4

± 4.4

-

≤ 0.5

-

≤ 0.5

-

± 3.5

The coefficient of variation CV, expressed as a percentage of the mean, was determined to
be ±3.3% and ±1.2% for the long-term reproducibility of the rectum and bladder probe
respectively. The ±3.3% quoted for the rectum probe reflects that of the central diode in
the array, however, the reproducibility of the other diodes in the array were also
measured and determined to be of similar nature to the central diode. The short-term
reproducibility of the both diodes was found to be better than 0.5% after consecutive
readings.
The MOSkinTM long-term reproducibility in the calibration jig was only measured twice
due to the limited availability of the CSDS readout unit borrowed from the CMRP at the
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University of Wollongong.
reproducibility of the MOSkin

As was the case for the diode probes, the short term
TM

was based on consecutive measurements. As shown in

Table 4.5, the short-term reproducibility of the MOSkinTM was significantly greater than
that for the diode probes with a variation of ±3.5%. The ±4.4% given for the long-term
reproducibility of the MOSkinTM reflects a change in sensitivity with accumulated dose
and incorporates both the random short-term reproducibility effect as well as the
systematic change in response with accumulated dose.

MOSFETs are known to

demonstrate a change in response with accumulated dose caused by radiation damage to
the sensitive SiO2 layer (Anelli 2000). Lavallee, Gingras & Beaulieu (2006) showed a
measurable decrease in sensitivity of a MOSFET with accumulated dose and
recommended recalibration of the MOSFET device for every 2,500 mV shift in threshold
voltage which corresponds to approximately 10 Gy.

4.3.4 Angular Dependence
Angular dependence results for the rectum probe and MOSkinTM as measured in the PTW
cylindrical calibration jig are shown in Figure 4.19.
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Figure 4.19 Polar plot of the angular response for the PTW rectum diode probe and MOSkinTM
normalised to the mean response of each detector over the 360º rotation.

The mean response was calculated for each dosimeter as measured over all the angles of
incidence. Each point was then plotted as a fraction of the mean value for that dosimeter.
The spread of values for the rectum diode were between -3.2% and +3.5% of the mean
with a coefficient of variation CV of ±3.2%.
For the MOSkinTM, the nominal 0º angle represented an orientation where the MOSFET
sensitive surface directly faced the source. The angular response of the MOSkinTM
ranged from -9.0% to +10% with a coefficient of variation CV of ±6.9%. This large
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variation in response has a distinct trend (as seen in Figure 4.19) with measurements
between 300º and 60º having a relative response greater than 1.05 while those
measurements between 90º and 270º having a response less than 1.00. This trend was
attributed to the silica backing board on which the MOSFET chip is mounted. This
backing resulted in extra attenuation of the photons when the backside of the MOSkinTM
was facing the source, hence the lower response observed between 90º and 270º.

4.3.5 Temperature Dependence
The temperature dependence of the two diode probes and MOSkinTM was evaluated to
determine whether the response of each dosimeter changed over a temperature range of
23º C to 40º C. As previously mentioned, the probes were simultaneously irradiated in a
beaker of water for 50 MU.

A total of three measurements were taken at each

temperature increment and the mean reading determined. All results are normalised to
the initial temperature of the tap water (23º C) and plotted as a function of temperature in
Figure 4.20.
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Figure 4.20 Plot of the temperature dependence of the PTW diode probes and MOSkinTM with
error bars. The readings for each dosimeter are normalised to the initial tap water
temperature of 23ºC.

The uncertainty in each measurement as displayed in Figure 4.20 is expressed by error
bars showing the maximum deviation of the three readings from the mean reading. In
Figure 4.20, the PTW bladder and rectum diodes show an increase in response to the
same delivered dose while the MOSkinTM shows a decrease in response. Over the whole
temperature range the bladder diode shows an overall increase of 2.4% (0.14% per degree
Celsius) while the rectum diode response increased by 1.2% (0.07% per degree Celsius).
On the other hand, the response of the MOSkinTM decreased by 2.0% (0.12% per degree
Celsius).
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4.3.6 Overall Uncertainty
Each of the influencing characteristics measured and described in the sections above
affect the overall uncertainty in dose measurement for each dosimeter. To get an idea of
the level of uncertainty for the PTW diode probes and MOSkinTM, the uncertainties of
each characteristic are summed to obtain a combined uncertainty for each dosimeter. The
energy dependence of the diodes and MOSkinTM under

192

Ir conditions was unable to be

quantitatively determined due to the limited ability of the reference dosimeter (ionisation
chamber) to accurately measure dose at distances close to the source and the
corresponding effects outlined in Section 4.3.1.1. As a result, energy dependence of the
dosimeters is omitted in this calculation. However, as indicated by the Monte Carlo data
presented in Chapter 3, the ratio of dose to silicon and water (DSi / DWtr) is as much as
25% higher for silicon compared with water at the calibration jig distance of 8 cm. The
issue of how the response of the diodes and MOSkinTM change with distance from the
source is further investigated in Chapter 5 by comparing measurements with the
treatment planning system (TPS).
The approach used for uncertainty calculation is based on the ISO guide to the expression
of uncertainty in measurement (Bentley 2002). The uncertainty contributed by each of
the measured dosimeter characteristics is given by ciui where ci is the sensitivity
coefficient and ui is the uncertainty of each measured quantity. The sensitivity coefficient
for each of the characteristics measured in this work is equal to 1 and the combined
uncertainty, u, is given by:

 A  2  R  2  S  2  T  2 
u  i(ci ui )             
 A   R   S   T  
2

2

(4.4)

where A, R, S and T represent the angular dependence, long-term reproducibility, shortterm reproducibility and temperature dependence respectively. Note that the short-term
and long-term reproducibility are combined in the case of the MOSkinTM as the long-term
reproducibility value incorporates the short-term reproducibility component, as discussed
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in Section 4.3.3. The term δ represents the uncertainty in each quantity and is divided by
the mean value of each quantity. For each of these characteristics the uncertainty is
calculated as a statistical uncertainty in terms of the standard deviation σ except in the
case of temperature dependence. These uncertainties are then expressed in terms of their
coefficient of variation CV (i.e. quotient of standard deviation and the mean) calculated as
a percentage relative to the mean. For the temperature dependence of each dosimeter, the
overall change in dosimeter response (%) over the whole temperature range is taken as a
worst case approximation.
If the coefficient of variation of a quantity x is CV 

X

, then Equation 4.4 can be

x

written as:



u 2  CV , A   CV , R   CV ,S   T 
which is

2



2

2

2



u 2  u A   u R   u S   uT 
2

2

2

2

(4.5)



(4.6)

The uncertainties of each influencing characteristic are listed in the table below and the
combined uncertainty calculated for each dosimeter:

Table 4.6

Combined uncertainty of each dosimeter due to influencing characteristics.

Influencing Characteristic (uX)

Rectum Probe

Bladder Probe

MOSkinTM

Angular Dependence (uA)

3.2%

3.2%

6.9%

Long – Term Reproducibility (uR)

3.3%

1.2%

Short – Term Reproducibility (uS)

0.5%

0.5%

Temperature Dependence (uT)

1.2%

2.4%

2.0%

Total (u)

4.8%

4.2%

8.4%
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4.4%

4.4

Discussion

The variation in energy response for each dosimeter was first observed in the difference
in calibration factor value (CF) obtained under the 192Ir cylindrical calibration jig set-up,
when compared to that under the 6 MV linear accelerator photon beam. Both diode
probes were consistent in showing a difference in CF of approximately 15% while the
MOSkinTM showed a slightly larger difference of 17.6%. The larger calibration factors
observed under

192

Ir irradiation agree with data published by other authors (Kron et al.

1998; Zilio et al. 2006) for silicon detectors at lower photon energies. The difference in
dosimeter CF for the linear accelerator beam when compared to the 192Ir source indicates
a change in energy response between megavoltage and kilovoltage (192Ir) energies. While
there is a clear change in energy response between these two energy ranges, the variation
in energy response of the diode probes and MOSkinTM at different distances from the 192Ir
source is more relevant for this work. In determining the best distance from the

192

Ir

source to calibrate the diode probes and MOSkinTM, it is evident from the energy response
curve in Figure 4.17 that an accurate calibration against the ionisation chamber close to
the source under the current set-up is difficult to achieve. The volume and cavity effects
that reduce the precision of the 0.6 cc ionisation chamber measurement are discussed in
Section 4.3.1.1. Tolli & Johansson (1993b) and Reynaert et al. (1998), have presented
data (Tables 4.3a, 4.3b and 4.4) quantitating these chamber effects at different distances
from an

192

Ir source for similar sized ionisation chambers to the one used in this study.

The main influencing effect on the ionisation chamber is the non-uniformity of the
electron fluence across the chamber volume resulting in volume averaging within the
chamber.

This explains the lower doses measured in the ionisation chamber when

compared to the diode probes and MOSkinTM at distances close to the source. At the
cylindrical jig calibration distance of 8 cm, the magnitude of these effects is much
smaller, having an influence of approximately 0.5 to 2% on the ionisation chamber
reading. This is within the measurement uncertainty. For the purpose of this work no
further investigation into these ionisation chamber effects was performed and no
corrections to the ionisation chamber readings are applied to the results in this chapter.
One encouraging characteristic of the energy response measurements was the good
agreement between the relative response of the diode probes and MOSkinTM in the slab
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set-up. This agreement tends to indicate that the high spatial resolution of these detectors
allows them to measure the dose at a similar point in the phantom (to within
approximately 5% of each other) in a high dose gradient region. Further investigation
into the energy response is performed in Chapter 5 in the absence of the ionisation
chamber.
Linearity and reproducibility effects for the diode probes are similar to those quoted by
(Waldhausl et al. 2005). In the case of the MOSkinTM, the linearity is comparable to the
diode probes while the reproducibility is slightly worse. This was most evident in the
short-term reproducibility values based on consecutive measurements where the
MOSkinTM reported a coefficient of variation CV of ±3.5% compared to ≤0.5% for the
rectum and bladder diodes. The uncertainties associated with long-term reproducibility
can be reduced by electing to calibrate the in vivo dosimetry system prior to each
treatment fraction.
The angular dependence of the rectum probe and MOSkinTM proved to be the property
with the greatest variation in response as the dosimeters were rotated through 360º
relative to the

192

Ir source. The response varied by as much as ±3.5% for the rectum

probe and by almost ±10% for the MOSkinTM. The large variation in response of the
MOSkinTM was attributed to the backing material on which the MOSFET sensor was
mounted.

This characteristic of the MOSkinTM lead to a larger overall uncertainty.

Angular dependence of a slightly modified version of the MOSkinTM has previously been
shown to have an angular dependence of approximately ±2% (Qi et al. 2007;
Wilkinson 2006). This modified MOSkinTM has the MOSFET mounted on a thin film
based material which provides minimal attenuation from any irradiation direction.
Temperature dependence was the last characteristic measured for the rectum probe,
bladder probe and MOSkinTM. All three probes showed a slight difference in response
over the temperature range from 23 to 40ºC. The rectum and bladder probes displayed an
increase in response of 0.07% and 0.14% per degree Celsius respectively, while the
MOSkinTM displayed a decrease of 0.12% per degree Celsius as the temperature of the
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water was increased in the beaker. While each dosimeter responded uniquely to the
increase in temperature, the overall effects are fairly minimal over the whole temperature
range; 1.2%, 2.4% and 2.0% for the rectum probe, bladder probe and MOSkinTM
respectively. The slightly larger results for the bladder and MOSkinTM may be related to
the thickness of these detectors and their ability to reach equilibrium with the temperature
of the water quicker than the thicker rectum probe. However, a conscious effort was
made to allow at least 3 to 5 minutes for the dosimeters to equilibrate with the water in
the beaker once the desired temperature as programmed on the heater-stirrer system had
been reached. Overall, these results for temperature dependence are slightly lower than
those of Waldhausl et al. (2005) who reported a change in response of 0.5% per degree
Celsius for the same diode probe system. Cheung et al. (2004) performed measurements
on an older CMRP MOSFET design and reported a total variation in response of 1.2%
over a temperature range of 22 to 45ºC when thermal equilibrium was established. These
results are comparable with the 2.0% change in response measured in this work for the
MOSkinTM.
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4.5

Conclusion

The outcome of this chapter was to characterise the PTW diode probes and MOSkinTM
dosimetry systems and examine how the influencing quantities of detector linearity,
reproducibility, energy response, angular orientation and temperature would affect the
accuracy of measurement for in vivo gynaecological HDR brachytherapy. Taking these
factors into account, the overall uncertainty in measurement for the PTW rectum and
bladder diode probes is 4.8% and 4.2% respectively. Waldhausl et al. (2005) measured
very similar characteristics for the same diode probe system and reported an uncertainty
of 7%.

The data collected in this study corresponds relatively well with that of

Waldhausl but with a slightly better overall uncertainty. In the case of the MOSkinTM the
overall uncertainty was found to be 8.4%. This was significantly higher than the two
diode probes but as mentioned in the discussion, this had a lot to do with the large
angular dependence seen with this particular MOSkinTM design. If the large angular
dependence for this particular MOSkinTM is ignored than the overall uncertainty for this
dosimeter is comparable to the PTW diode probes.
A method of calculating calibration factors for each of the PTW diode probes and
MOSkinTM to relate dosimeter reading to dose is proposed in this chapter. While this
method allows the dose measured on the dosimeters to be traceable to a standards
laboratory, there are some concerns on its accuracy when measuring dose in close
proximity to a HDR 192Ir brachytherapy source.
The end result of this chapter shows that the inherent characteristics and associated
uncertainties of the two dosimetry systems are comparable to other dosimetry systems
described throughout the literature (Anderson et al. 2009; Lambert et al. 2007).
Anderson et al. (2009) reported a standard uncertainty for Al2O3:C optically stimulated
luminescence (OSL) and radioluminescence (RL) dosimetry systems of 5% and 8%
respectively in a measurement range of 0.5 to 5 cm from an
(2007) claimed that the BrachyFOD

TM

192

Ir source. Lambert et al.

system is accurate to within 3% for distances

between 1 and 10 cm from a HDR 192Ir source.
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Chapter 5:
Calibration and Implementation of an in vivo
Dosimetry System for High Dose Rate
Gynaecological Brachytherapy
5.1

Introduction

The current practice for gynaecological HDR brachytherapy at The Canberra Hospital
involves an initial applicator insertion performed by the radiation oncologist, sometimes
with the patient under anaesthetic, followed by a CT of the vaginal and uterine cavity
with the applicators in place. The CT images are sent to the NucletronTM PLATO
treatment planning system (TPS) via the network where the applicators are reconstructed
and the dose is prescribed for the treatment. For the organs at risk that lie in close
proximity to the treatment region, in this case the rectum and bladder, points are placed
on the treatment plan to estimate the dose they will receive. For the rectum, these points
are placed along the mucosa of the anterior rectum wall as this is the region closest to the
implant and will likely receive the highest dose. Likewise for the bladder, the point is
placed on the posterior wall.

These points are labelled ICRU rectum and bladder

respectively and are used as a means of dose reporting. The brachytherapy treatment
planning system (TPS) is used to calculate the dose to these points placed on the organs
at risk to determine the amount of dose they will receive during the treatment. However,
there are well known limitations to this calculation caused predominately by the nonconsideration of heterogeneities by the TPS and the assumption of full scattering
conditions. The implementation of an accurately calibrated in vivo dosimetry system
poses as a useful tool to pick up any errors in calculating the dose to the organs at risk by
the treatment planning system.
Following the characterisation of the PTW rectum and bladder diode probes and the
CMRP MOSkinTM in the previous chapter, the next step was to develop a routine
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calibration procedure for the dosimeters in order to implement them into clinical
gynaecological brachytherapy treatment. The calibration procedure needs to be simple,
reproducible and accurate to ensure that meaningful results can be obtained. It is also
necessary that the calibration procedure can be performed in a short time period so that
calibration of the probes can be carried out on the morning of the treatment prior to
applicator insertion.

5.2

Materials and Methods

Implementing the dosimetry probes in the current gynaecological brachytherapy
procedure involves a few extra steps at each of the four stages of treatment, i.e. at the
insertion of the applicators, simulation of the patient, planning of the treatment and the
dose delivery to the patient. The dosimeters are inserted into the rectum and bladder by
the radiation oncologist following applicator insertion but prior to the imaging of the
patient. The patient is then imaged, generally by computed tomography (CT), with the
dosimeters inside the patient so that they appear on the patient CT image. Once the
image dataset is in the treatment planning system (TPS) and the applicators have been
reconstructed, the position of each of the diodes or MOSkinTM inside the rectum and
bladder is marked on the relevant CT slices in the TPS. The dose calculated by the
treatment planning system to each diode is then noted and later compared to the dose
measured in the patient.

5.2.1 Calibration Equipment
Most of the equipment used for the calibration of the PTW probes and MOSkinTM has
been described in the previous chapter. This includes the PTW cylindrical jig shown in
Figure 4.6, the perspex slab phantom (Figure 4.13), the dosimetry probes, the Farmer
ionisation chamber and the associated electrometers and dosemeters that accompany each
device. Note that all measurements performed with the rectum probe are based on the
dose measured on the central diode in the array.
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5.2.2 NucletronTM PLATO Treatment Planning System (TPS)
At The Canberra Hospital, brachytherapy treatments are planned on the NucletronTM
PLATO treatment planning system (TPS), version 14.3.5. Following the importation of
the patient CT data set, applicators are reconstructed and dwell points are placed to
deliver the prescribed dose to a reference point such as ‘Point A’ for cervix procedures.
The TPS calculates dose according to the TG-43 algorithm described in Section 2.2.3.
This algorithm calculates the dose to a point in space based on its distance from the
source in a homogenous “tissue equivalent” or water medium assuming full scatter
conditions. In reality it is likely that there will be heterogeneities within the treatment
region including air in the rectum and stainless steel or titanium in the applicators. As a
result, the TPS may under-estimate or over-estimate the dose to the treatment region and
the surrounding rectum and bladder, which can lead to acute and late tissue
complications. As outlined in the sections to follow, the TPS was employed both as an
independent check of the in vivo dosimeter calibration process as well as a tool for
directly calibrating the PTW diode probes and MOSkinTM.

5.2.3 CT of Calibration Phantoms and the Reconstruction of the
Source Applicator and Diode / MOSkinTM Probes
In order to use the TPS, the PTW cylindrical phantom and perspex slab phantom were
both individually scanned on the Philips Medical Systems AcQSIM CT with the stainless
steel applicator, diode probes, MOSkinTM and ionisation chamber placed inside the
phantom for the scan. Axial slices with a width of 2 mm and slice separation of 2 mm
were obtained for each phantom and sent to the TPS via the computer network. The
applicator and diodes were reconstructed on the TPS and were identified by the bright
artifacts on the CT slices shown in Figure 5.1. Each diode in the rectum probe array as
well as the bladder diode and ionisation chamber were marked as ‘patient’ points and
given co-ordinates in space relative to the co-ordinate axes. The co-ordinate axes were
defined to be along the axis of the source applicator once the applicator had been
reconstructed. A single dwell point was placed in the source applicator at a distance of
995 mm to coincide with the centre of the ionisation chamber sensitive volume, the
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bladder diode, MOSkinTM and the central diode in the rectum probe array. By entering in
a manual source dwell time of 300 seconds a dose distribution in the phantom was
obtained and the dose to each of the ‘patient’ points, representing the diodes, MOSkinTM
and ionisation chamber respectively, was calculated by the TPS.

Figure 5.1 CT image of the PTW cylindrical PMMA phantom in the PLATO treatment planning
system. The diode probes and applicator are reconstructed from the bright artifacts
on the CT image while the ionisation chamber sensitive volume is identified by the
small air pocket with the thin aluminium electrode in the centre.
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5.2.4 Calibration of the Dosimeters in the PTW Cylindrical
Calibration Jig and Slab Phantom
The operation of the PTW cylindrical jig and the calibration of the PTW diode probes and
MOSkinTM against the ionisation chamber are described in the previous chapter, Sections
4.2.4 and 4.2.5. The expression used to calculate the calibration factor for each detector
in 192Ir is given by Equation 4.1 and is shown again below:

CF 

M Diode
water

 
M ion  N K  kTP  kelec  ku   en 
 pu

 air


(5.1)

Once the calibration factors (CFs) are determined for each of the PTW diode probes and
MOSkinTM then the dose measured in the cylindrical jig can be compared to the dose
calculated by the TPS.

5.2.5 Calibration in the Perspex Slab Phantom
Like the PTW cylindrical jig phantom, the slab phantom was imaged on the CT unit with
the rectum probe positioned at the calibration distance of 8 cm from the source (Figure
5.2). The source applicator and diodes were then reconstructed in the TPS and the dose
was calculated out to the 8 cm dosimeter position and later compared with the measured
dose. Calibration factors were measured in the slab phantom for the central diode in the
rectum probe array and the MOSkinTM only. Due to the nature of the slab phantom, only
one detector could be irradiated at a time. Due to the limited time available, a calibration
factor was not determined for the bladder probe. The ionisation chamber, rectum probe
and MOSkinTM were each individually irradiated for a duration of 300 seconds
respectively. The calibration factors were calculated from the reading of each dosimeter
at the calibration distance of 8 cm from the source. These calibration factors were
compared with those measured in the cylindrical jig and then with the dose calculated by
the TPS at the 8 cm distance. Using these calibration factors determined at 8 cm, the
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dose was also measured at distances of 5 cm and 2.3 cm in the slab phantom with the
rectum probe and MOSkinTM to observe how close the measured dose matched the dose
calculated by the TPS.

Figure 5.2 Image of the central diode in the rectum probe array and the source applicator inside
the perspex slab phantom as reconstructed in the PLATO treatment planning system.
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One problem with imaging the slab phantom was that the diode probe or other dosimeters
could only be positioned at one distance from the source applicator for each CT scan.
Instead of imaging the phantom multiple times with the detectors positioned at different
depths in the phantom, ‘applicator’ points were placed on the plan as shown in Figure
5.3. These applicator points were used to determine the dose as calculated by the TPS for
each of the source-to-dosimeter distances used in the energy dependence measurements
described in the previous chapter, Section 4.2.5.3.

Figure 5.3 Three-dimensional reconstruction of the source applicator, rectum diodes and
applicator points in the PLATO treatment planning system.
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5.2.6 The Effect of Phantom Size, Shape and Material on
Dosimetry
The influence of phantom size and shape has been shown to have a significant impact on
dose distribution around brachytherapy sources (Tedgren & Carlsson 2009; Granero et al.
2008; and Perez-Calatayud, Granero & Ballester 2004). In particular, boundary effects in
phantoms of finite dimensions can cause variation in dose distribution due to loss of
backscatter photons close to the phantom boundary.

Careful consideration of these

effects should be taken into account when comparing measured data to either Monte
Carlo simulated data, calculations performed in the treatment planning system, or data
published by other authors in the literature. Williamson & Li (1995) pointed out this
discrepancy when comparing the dose rate along the transverse axis of the
microSelectron ‘Classic’ PDR source simulated in their unbounded Monte Carlo medium
to that in a 30 cm diameter sphere with the dose rate 12% larger in the unbounded
medium.

Perez-Calatayud et al. (2004) and Tedgren & Carlsson (2009) have also

simulated the effects of phantom size on dose distribution for

192

Ir sources highlighting

the differences in dose along the transverse axis for bound and unbounded phantoms
(Figure 5.4).

114

Figure 5.4 Ratio of

radial dose functions for phantom size R and that for an unbounded

phantom simulated by a 192Ir point source (Perez-Calatayud et al. 2004).

Granero et al. (2008) quantitated the effects of phantom size on dose distribution for 192Ir
and

137

Cs sources using Monte Carlo techniques and came up with a formalism to

calculate equivalent phantom sizes for spherical, cylindrical and cubic phantom shapes.
Determinining the equivalent phantom size is particularly useful when comparing the
absorbed dose to water calculated by the treatment planning system (TPS) to that
measured in physical phantoms of different shapes and sizes. Typically, the NucletronTM
treatment planning systems such as PLATO calculate absorbed dose to water in a water
sphere of diameter 30 cm (Tedgren & Carlsson 2009), whereas physical phantoms tend to
be cubic, rectangular or cylindrical in shape. Tedgren & Carlsson (2009) extended the
work of Granero to include the effects of phantom material on dose distribution in
addition to the size of the phantom. Figure 5.5 is taken from Tedgren & Carlsson (2009)
and shows the difference in dose particularly near the phantom boundary for a cylinder
20 cm in height and diameter relative to a cylinder with a height and diameter of 30 cm.
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Figure 5.5 Ratios of absorbed dose to water calculated in cylindrical phantoms of height 20 cm,
diameter 20 cm and absorbed dose to water in a water cylinder of height 30 cm,
diameter 30 cm (Tedgren & Carlsson 2009).

5.2.7 Accounting for the Loss of Scatter Material in the PTW
Cylindrical Calibration Jig
As shown in Figure 4.8, the PTW cylindrical calibration jig has a diameter of 20 cm,
height of 12 cm and as previously mentioned, an additional 9 cm of perspex slabs were
placed underneath the jig for measurements performed with the diode probes, MOSkinTM
and ionisation chamber. However, as described in the literature presented in the previous
section, the lack of scatter material behind each of the dosimeters in the jig will result in a
discrepancy between the measured dose and the dose calculated by the TPS.

To account for the difference in dose due to the lack of scatter behind the jig, further
Monte Carlo simulations were performed in the EGSnrc code based on the ‘Classic’
source model described in Chapter 3. For these simulations, dose was scored in 1 mm
voxels, at distances ranging from 1 to 9.5 cm along the transverse axis of the source. A
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water cylinder 28 cm in height and diameter with the

192

Ir at the centre was used for

simulation of the PLATO TPS dose calculation environment . This was shown by
Granero et al. (2008) to be equivalent to the 30 cm diameter spherical water phantom
employed by the TPS for its dose calculation. For the case of the PTW cylindrical jig, a
PMMA cylinder of diameter 20 cm, height 12 cm was used with an additional 9 cm of
material included underneath to mimic the experimental set-up described in Section 4.2.4.
To compare the scattering properties of PMMA and water, an identical shaped water
cylinder to the one used to model the PTW cylindrical jig was also simulated. All
simulations were run with sufficient histories to gain an uncertainty of less than 1.5% at
all measured depths in the cylindrical phantoms.
Using the formalism described by Tedgren & Carlsson (2009), the absorbed dose to water
in the 28 cm height and diameter water cylinder representing the TPS is denoted as Dw,w.
The absorbed dose to PMMA in the PMMA cylindrical jig phantom is denoted as
Dphan,phan and the absorbed dose to water in the PMMA cylindrical jig phantom as Dw,phan.
Similarly, the absorbed dose to water in the hypothetical water cylindrical jig phantom is
also described by Dw,phan for the purpose of demonstrating the difference in scattering
properties of PMMA compared to water.
The absorbed dose to water at a point in the phantom is obtained by the relation:

Dw, phan



where  en / 



w
phan


  en
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D phan , phan

 phan

(5.2)

is the ratio of mass-energy absorption coefficients for water and the

phantom material at the average photon energy calculated from the Monte Carlo spectral
data for the

192

Ir source presented in Chapter 3. The ratio of mass-energy absorption

coefficients for the average photon energy at each of the depths shown in Table 3.4 (i.e.
1, 5, 8 and 10cm) is taken from data published by Hubbell & Seltzer (2004). By plotting
the ratio of mass-energy absorption coefficients as a function of distance from the source,



a third-order polynomial function was fitted so that  en / 



w
phan

could be applied to all the

Dphan,phan data points scored in the Monte Carlo simulations. The Monte Carlo derived
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values of Dphan,phan were multiplied by the square of the radial distance from the source to
negate the effects of the inverse square law as this is independent of the phantom
properties. The resultant dose profiles were fitted to a fifth-order polynomial to represent
the Dphan,phan data and eliminate the influence of statistical noise in the Monte Carlo
absorbed dose data. The polynomial fitted curves show good correlation with the Monte
Carlo data such that the polynomial fit is always within ± 2% of the original data.

5.2.8 Calibration of the PTW Diode Probes and MOSkinTM with
the Treatment Planning System
Due to the nature of the known energy dependence of semiconductor dosimeters, it would
seem desirable to calibrate the dosimeters at distances close to the source where they will
be clinically used. However as demonstrated in the previous chapter, it is very difficult to
obtain an accurate calibration close to the source due to the large volume of the ionisation
chamber placed in a steep dose gradient region.
An alternative method to calibrating the rectum probe, bladder probe and MOSkinTM is to
directly calibrate these dosimeters against the TPS. It is assumed that the TPS correctly
calculates the dose in a uniform water phantom under full scatter conditions. Therefore,
by recreating a similar environment in the slab phantom with full scatter, it is possible to
directly relate the dose calculated by the TPS to the relative dosimeter reading measured
at the same point in the slab phantom. This is achieved by using the energy response data
measured in the slab phantom at source to detector distances of 2.3 cm to 8 cm (see
Figure 4.16, Section 4.3.1.1). The TPS dose was taken from the doses calculated to the
applicator points in Figure 5.3 for a source dwell time of 300 seconds. The calibration
factor in this case is simply the ratio of the diode or MOSkinTM reading (M) after
300 seconds and the dose calculated by the TPS (DTPS) at the closest source to detector
distance of 2.3 cm.

CF 

M Diode @ 2.3cm
DTPS @ 2.3cm
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[reading cGy-1]

(5.3)

The dosimeter readings for each point of measurement are then divided by this calibration
factor to obtain the dose for that particular point. This dose can then be compared to the
dose calculated by the TPS at the corresponding applicator point.
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5.3

Results

The results measured for each of the dosimeters are compared with the dose calculated by
the TPS. The results are separated into those measured in the cylindrical calibration jig
and those obtained in the perspex slab phantom.

5.3.1 Calibration in the PTW Cylindrical Jig
As outlined in the method, calibration factors were determined for both diode probes and
the MOSkinTM by irradiating all dosimeters simultaneously with the ionisation chamber
within the cylindrical jig phantom. The calibration factors were expressed in terms of the
diode or MOSFET reading (in nC and mV respectively) per cGy as measured by the
ionisation chamber. These are displayed in Table 5.1 below:

Table 5.1

Calibration Factors for the rectum probe, bladder probe and MOSkinTM in the PTW
cylindrical jig.

Rectum Probe CF

Bladder Probe CF

MOSkinTM CF

(nC cGy-1)

(nC cGy-1)

(mV cGy-1)

23.52 ± 0.07

23.95 ± 0.06

2.80 ± 0.07

The dose measured by the ionisation chamber in the cylindrical jig, and hence the dose
measured by the diode probes and MOSkinTM as a result of the calibration process, was
calculated to be 40.32 cGy. This dose was compared to the dose calculated by the TPS
for each of the dosimeters as reconstructed in the cylindrical jig CT data set shown
previously in Figure 5.1. The results are shown in Table 5.2:
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Table 5.2

Comparison of measured dose and the dose calculated by the PLATO TPS for each
dosimeter when placed in the PTW cylindrical jig.

Detector

TPS Dose (cGy)

Measured Dose (cGy)

% Difference to TPS

Ion Chamber

44.09

40.32

- 8.6

Rectum Probe

44.09

40.32

- 8.6

Bladder Probe

44.09

40.32

- 8.6

44.09

40.32

- 8.6

TM

MOSkin

The results in Table 5.2 indicate that there is a 8.6% difference between the measured
dose in the calibration jig and the dose calculated by the TPS. This discrepancy is
attributed to the difference in how the TPS considers the scattering conditions
surrounding the source and dosimeters. As mentioned earlier, the cylindrical calibration
jig has a diameter of 20 cm which means that there is only 2 cm of scatter material behind
each of the dosimeters. On the other hand, even though the dimensions of the calibration
jig remain the same in the reconstructed CT data set, the calculation performed by the
TPS is done so in a water sphere of diameter 30 cm. Therefore this additional scatter
material that the TPS artificially and incorrectly creates, results in a greater dose
calculated to each dosimeter.

5.3.2 Quantifying the Effects of Loss of Scatter Material in the
PTW Cylindrical Calibration Jig
The difference in measured and TPS calculated dose indicates that the dosimeters in the
calibration jig receive 8.6% less dose, most likely as a result of lack of scatter material
behind the point of measurement when compared to the geometry used for calculation by
the TPS. In an attempt to quantify this discrepancy in dose and observe the effects of loss
of scatter material beyond the cylindrical jig, Monte Carlo simulations were performed to
compare the absorbed dose along the transverse axis in the PMMA jig and the TPS
(Figure 5.6). As previously mentioned, the PTW cylindrical jig is replicated by the
PMMA cylinder under the same geometry used for experimental measurement, while the
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TPS spherical water phantom is equivalent to a cylinder of water with a height and
diameter of 28 cm.

1.05

1.00

Dw, phan / Dw, w

0.95
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0.85

PMMA Cyld = 20cm / TPS Wtr Cyld = 28cm
Wtr Cyld = 20cm / TPS Wtr Cyld = 28cm
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0
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Figure 5.6 Monte Carlo simulated ratios of absorbed dose to water calculated in PMMA and
water cylinders of diameter and height 20 cm relative to the TPS geometry equivalent
water cylinder with a height and diameter of 28 cm.

The Monte Carlo data in Figure 5.6 clearly shows the difference in dose for the PMMA
cylinder when compared to the geometry of the TPS, particularly at the edge of the
phantom.

At the reference point of 8 cm used for dose measurement in the PTW

cylindrical PMMA jig, the Monte Carlo data indicates that the absorbed dose to water is
10.1% less than that calculated by the TPS. This corresponds relatively well with the
8.6% difference observed in the measured data for the ionisation chamber, diodes probes
and MOSkinTM when compared with the TPS. In addition, the absorbed dose to the
hypothetical water cylinder with dimensions identical to the PTW jig is also shown in
Figure 5.6. In this case the difference between the 20 cm diameter water cylinder and the
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TPS geometry is approximately 7.3% at 8 cm and not as large as that observed in
PMMA.

This difference between PMMA and water for the same sized phantom

demonstrates the difference in attenuation and scattering properties of the two materials.
In the case of PMMA, the greater attenuation of photons in the denser medium is no
longer compensated for by the larger backscatter contribution at the edge of the phantom
due to the lack of scatter material beyond the calibration jig.
Therefore, in order to make a comparison of dose measured in the calibration jig with the
dose calculated by the TPS, a scatter correction factor must be applied to the readings in
the calibration jig. The expression for dose in the calibration jig (Djig) in this case is
given by:

D jig  M Det  CFDet  Bscatter

(Gy)

(5.4)

where MDet is the reading of either the diode, MOSkinTM or ionisation chamber, CFDet is
the calibration factor for the appropriate detector and Bscatter is the scatter factor applied
from the Monte Carlo data in Figure 5.6. Only with the use of equation 5.4 can the dose
calculated in the calibration jig be adequately compared with the TPS.

5.3.3 Calibration in the Slab Phantom
To try and nullify this difference in scattering conditions between the calibration jig and
the TPS, a calibration was also performed in the perspex slab phantom that provided
12 cm backscatter behind the source and dosimeter. The calibration distance of 8 cm was
maintained and the calibration factor (CF) was calculated in the same way as described
for the calibration jig. As shown in Table 5.3, these measured calibration factors matched
those determined in the calibration jig extremely well for the rectum probe such that the
two CFs agreed within 0.4%. Meanwhile the CF for the MOSkinTM was calculated to be
3.3% higher in the slab phantom compared to the cylindrical jig.
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Table 5.3

Comparison of the CFs for the dosimeters as measured in the slab phantom and PTW
cylindrical jig.

Rectum Diode Probe (nC cGy-1)

MOSkinTM (mV cGy-1)

Slab Phantom CF

23.42 ± 0.07

2.90 ± 0.07

Cylindrical Jig CF

23.52 ± 0.07

2.80 ± 0.07

- 0.4%

+ 3.3%

% Diff between Slab
and Jig Phantoms

The calibration factors for both these dosimeters, as determined in the slab phantom setup, were then used to measure the dose at distances of 8 cm, 5 cm and 2.3 cm from the
source using the same slab phantom. These were then compared to the doses calculated
by the TPS at each of the corresponding applicator points previously shown in Figure 5.3.

Table 5.4

Comparison of the dose measured with the calibrated dosimeters with that calculated
by the TPS.

Distance
(cm)

TPS
Dose
(cGy)

Dose
Ionisation
Chamber
(cGy)

% Diff
to

Dose
Rectum
Probe

TPS

(cGy)

%Diff

Dose

% Diff

to

MOSkinTM

to

TPS

(cGy)

TPS

8

43.93

42.82

-2.5

42.82

- 2.5

42.82

- 2.5

5

118.93

111.99

-5.8

114.24

- 3.9

108.43

- 8.8

2.3

569.89

460.76

-19.1

499.91

- 12.3

481.72

- 15.5

As shown in Table 5.4, the dose measured by the ionisation chamber, rectum probe and
MOSkinTM in the slab phantom at the calibration distance of 8 cm agrees with the TPS to
within approximately 2.5%. This is an improvement from the 8.5% discrepancy seen
with the cylindrical jig (without accounting for the loss of scatter) and is attributed to the
additional scatter material behind the dosimeters provided in the slab phantom. However,
as the dosimeters are placed closer to the source, the difference between the measured
dose and the dose calculated by the TPS increases. In the case of the rectum probe, at
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distances of 5 cm and 2.3 cm from the source, the measured dose is less than the TPS by
3.9% and 12.3% respectively. The MOSkinTM results show an even larger discrepancy of
8.8% and 15.5% respectively for the same positions in the phantom. Likewise, the
ionisation chamber measurements show the same trend with a discrepancy of 5.8% and
19.5% at 5 cm and 2.3 cm respectively. In the case of the ionisation chamber, the nonuniformity (pn / pV) and displacement effects (pd) discussed in Section 4.3.1.1
significantly influence the recorded results of the ionisation chamber at distances close to
the source.
To put into perspective the errors between the dose measured and dose calculated by the
TPS, the dose fall-off away from the central axis of the source was plotted based on the
dose calculated at each of the applicator points in the slab phantom plan (Figure 5.3). The
fall-off in dose at distances of 1.5 to 8 cm from the

192

Ir source are shown in Figure 5.7.

As mentioned in Chapter 3, the data used by the TPS algorithm for calculation of dose is
based on Monte Carlo data published by Williamson & Li (1995) and is reported to have
an uncertainty of less than 2%.
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Figure 5.7 The dose fall-off with distance from the

192

Ir source as calculated by the treatment

planning system.

Figure 5.7 shows an approximate inverse square fall-off in dose with a steep dose
gradient in the first few centimetres from the source. In this steep dose gradient region,
the 12.3% difference between the dose measured with the rectum probe at 2.3 cm from
the source and the dose calculated by the TPS at the same point corresponds to a distance
to agreement (DTA) value of 1.5 mm. Similarly, the 15.5% difference observed at the
same distance with the MOSkinTM corresponds to a DTA of 2 mm. Therefore, any small
error in positioning of the dosimeter or reconstruction of the source applicator and dose
points in the TPS leads to what appears to be a significant difference in measured and
TPS calculated dose. In reality, the error is in the order of millimetres due to the rapid
nature of dose fall-off around brachytherapy sources. The DTA results for the measured
and TPS calculated doses at 2.3 and 5 cm from the source are shown in Table 5.5.

126

Table 5.5

Distance to agreement (DTA) with TPS calculated dose for the rectum probe and
MOSkinTM.

Distance from Source (cm)

DTA for Rectum Probe (cm)

DTA for MOSkinTM (cm)

2.3

0.15

0.20

5.0

0.07

0.20

5.3.4 Calibration with the Treatment Planning System
The results described in this section are based on directly calibrating the PTW diode
probes and MOSkinTM with the TPS in the absence of an ionisation chamber. The relative
depth-dose was calculated at each point in the slab phantom and normalised to the dose at
a distance of 2.3 cm for the three dosimeters as well as the TPS. The relative dosimeter
response was then plotted as a function of distance from the source and is displayed in
Figure 5.8.
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Figure 5.8 The relative depth-dose curves for the rectum probe, bladder probe and MOSkinTM
normalised to the response of each dosimeter at 2.3 cm from the source. The relative
dose at each distance from the source is also compared to the corresponding dose
calculated by the PLATO TPS.

The relative dose measured at each point by all three dosimeters shows reasonably good
agreement with the TPS over most distances as displayed in Figure 5.8. For the rectum
and bladder probe the maximum difference between what is measured and the TPS is
3.2% and 5.0% respectively. Most values for both probes are within 2% at distances
close to the 2.3 cm calibration point with larger deviations seen at the measurement
points further from the source. These results are mirrored by the MOSkinTM, with a
maximum difference of 4.4% seen for points between 2.3 and 5 cm, while much larger
discrepancies of up to 15% are observed at 8 cm.
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5.3.5 Energy Response Compared to Monte Carlo Data
The Monte Carlo data presented in Chapter 3 indicated a difference in the dose deposited
in a silicon voxel when compared to the dose to water at the same distance from the
source in a water phantom. This difference was found to be more prominent at larger
distances from the source due to the greater number of low energy scattered photons. The
measured results for the diode probes and MOSkinTM also show some deviation from the
dose calculated by the treatment planning system (TPS), reported in the previous section
and shown in Figure 5.8. As highlighted in Chapter 3, these differences between the
measured dose and the dose calculated by the TPS could partially be related to the change
in response of the silicon dosimeters especially at distances away from the source. Figure
5.9 is a plot of the ratio of dose for each dosimeter (DDiode) and the dose to water
calculated by the TPS (DWater) normalised at 2.3 cm. The ratio of dose to silicon and

Normalised Energy Response Relative to TPS

water (DSi / DWater) determined in the Monte Carlo work is displayed for comparison.
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Figure 5.9 The ratio of dosimeter reading and the dose to water calculated by the TPS. The
Monte Carlo derived ratio of dose to silicon and water is provided for comparison.
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The Monte Carlo data shows a progressive increase in the ratio of dose to silicon relative
to dose in water with distance from the source. This represents a change in energy
response in silicon at these points. The data based on measurement for each of the
dosimeters doesn’t show the same magnitude of difference relative to the TPS, although
the results for the MOSkinTM show some increase in response at the larger distances from
the source. For the case of the rectum and bladder diode probes, the expected trend is not
apparent and the variations from the TPS appear to be spread randomly. For the current
data presented in this chapter, no corrections for change in energy response are applied
for any of the dosimeters.
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5.4

Discussion

Calculating the calibration factors and determining the dose to each of the dosimeters in
the PTW cylindrical calibration jig yielded an 8.6% disagreement in dose between what
was measured and what was calculated by the treatment planning system (TPS). Despite
the fact that an image data set of the same phantom was used for the dose calculation in
the TPS, the inability of the TPS to differentiate the air around the cylinder and any other
heterogeneous material means that the measurement environment and the environment in
which the dose calculation is performed are never the same. The extra scatter material
that the TPS assumes to exist around the cylindrical phantom leads to the TPS
overestimating the true dose that is delivered to the rectum probe, bladder probe,
MOSkinTM and ionisation chamber. The difference in scattering conditions between the
cylindrical jig measurements and the TPS were quantified by further Monte Carlo
simulations. The Monte Carlo data showed that the absorbed dose to water measured in
the PMMA cylindrical jig, with only 2 cm of scatter material behind each of the
dosimeters, led to approximately 10% less dose at the calibration distance of 8 cm than
calculated in the TPS (Figure 5.6). This 10% difference predicted by Monte Carlo is in
good agreement with the 8.6% discrepancy observed between the measured and TPS
results. Tedgren & Carlsson (2009) and Perez-Calatayud et al. (2004) have published
similar results in the literature that highlight the loss of dose due to lack of scattering
material. As shown in Figure 5.5, Tedgren found an 8% difference in absorbed dose to
water at 8 cm measured in a PMMA cylindrical phantom of 20 cm diameter and height
when compared to a cylinder of 30 cm height and diameter.

Perez also showed a

difference of approximately 11% in radial dose functions g(r) for a cylinder of 10 cm
radius when compared to an unbounded phantom (Figure 5.4). The difference in results
found in this work to that of the literature are small and are attributed to variations in
sources and source modelling, the method of determining the energy spectrum at different
depths and hence the values used for mass-energy absorption coefficients and lastly the
use of different sized phantoms. By applying the 10% difference calculated by Monte
Carlo as a correction factor for loss of scatter, the dose results in the jig set-up now agree
with the TPS to within 2%.
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Given the significant effect that the phantom geometry and scattering conditions have on
the agreement between measured and TPS results, an attempt was made to create a
measurement environment that would effectively match the environment used by the TPS
for dose calculation. Meli et al. (1988) suggested that full scattering conditions could be
obtained in a solid phantom by providing at least 7 cm of scatter surrounding the source
and dosimeter. The perspex slab phantom allowed the calibration of each dosimeter
under full scatter conditions with 12 cm of material surrounding both the detector and the
source. Any increase in scatter dose from the denser perspex material would be balanced
out by the increased attenuation of the primary photons. Calibrating the rectum probe
and MOSkinTM against the ionisation chamber at 8 cm in the slab phantom showed an
improved agreement of 2.5% between the measured dose and the dose calculated by the
TPS at this distance. This 2.5% difference between the measured dose and TPS at 8 cm
is within the uncertainty in measurement for each of the dosimeters based on their
inherent characteristics described in Chapter 4. Additionally, the nature of the axial slices
obtained for the CT data set with 2 mm slice width and 2 mm slice separation means that
the diodes, MOSFET or ionisation chamber volume can appear on more than one slice or
in-between slices leading to an uncertainty in spatial positioning of the reconstructed
detector points and applicator points relative to the source position.
When the calibration factors obtained in the perspex slab phantom for the rectum probe
and MOSkinTM were used to measure the dose at 2.3 cm from the source, the measured
dose was found to be less than the TPS by approximately 12% and 15% respectively.
The dose difference at this distance is significant and is attributed primarily to error in
positioning. At close proximity to the source, any small variation in positioning of the
dosimeter is significantly magnified due to the large dose gradient in this region. This is
evident with the calculated distance to agreement equaling 1.5 mm and 2 mm for the
rectum probe and MOSkinTM respectively at the closest point of measurement. Note that
at the distances close to the source, the dose calculated by the TPS is based on applicator
points created within the co-ordinate system and not on a reconstructed detector. As a
result the position of the applicator points may slightly differ from the effective point of
measurement of the detector creating a small displacement error, again resulting in a
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large difference in dose in this steep dose gradient region. The ionisation chamber was
also used for measuring dose at 2.3 cm and recorded an even larger difference to the TPS
of 19% but as discussed earlier, suffers from the volume averaging effects described in
Chapter 4. Other effects that could have contributed to this discrepancy in dose are the
inherent characteristics of the dosimeters described in the previous chapter, the poor
spatial resolution of the ionisation chamber when determining the dosimeter calibration
factor (CF), and a possible change in energy response of the diode probes and MOSkinTM
over the range of measurement.
The final method proposed for calibrating the diode probes and MOSkinTM involves direct
calibration with the TPS. The advantage of this method is that the dosimeters can be
calibrated in terms of dose without the uncertainty associated with the ionisation chamber
volume. Furthermore, the probes can be calibrated close to the source, which is more
representative of where they are used clinically. By normalising the readings of the
rectum probe and MOSkinTM with the treatment planning system at 2.3 cm, an improved
agreement was found between the dosimeters and TPS, especially at distances within
5 cm of the source where all points were within 5%. In the case of the MOSkinTM, a
discrepancy of 15% was recorded at 8 cm for this method and again could be due to a
change in energy response. The limitation of this method is that it assumes that the
rectum diode and MOSkinTM are measuring dose at exactly the same point as the TPS in
the steep dose gradient region. In addition, this method of calibration for the rectum
probe and MOSkinTM is not truly independent of the TPS which was stated in the first
chapter as one of the reasons for a HDR brachytherapy in vivo dosimetry program.
This effect of change in response for both the diode probes and MOSkinTM is further
investigated by plotting the relative response of the dosimeters and comparing them with
the predicted change in energy response of silicon dosimeters as determined by the Monte
Carlo data presented in Chapter 3. Figure 5.9 shows that the change in response of
silicon relative to water as calculated by Monte Carlo is not observed to the same extent
in the measured results. This indicates that the use of a pure 1 mm silicon voxel used to
approximate the silicon based dosimeters for the Monte Carlo work is not an accurate
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representation of the response of each dosimeter under measurement conditions. In the
case of the rectum and bladder diode probes, there is no clear trend in the change in
response of the probes with distance from the source. For the MOSkinTM, there appears
to be some increase in response with distance but shows some inconsistencies at certain
data points. Qi et al. (2007) reported a change in energy response with distance from an
192

Ir source for a similar MOSFET design from the CMRP.

They showed that by

normalising the response of the MOSFETs at 5 cm, difference in responses were as much
as 8.9% and 20.9% at distances of 2 cm and 1 cm from the source respectively. To
account for these changes in response, distance dependent corrections were applied to
each individual MOSFET. Due to the inconsistencies observed in the energy response
data in this work, it is difficult to apply a correction factor with good confidence for the
MOSkinTM without further measurement and the collection of more data.
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5.5

Conclusion

This chapter evaluated three different methods of calibrating the rectum probe, bladder
probe and MOSkinTM in order to measure dose in the vicinity of an
brachytherapy source.

192

Ir HDR

Each method described in the sections above has its own

advantages as well as limitations whether they be physical, experimental, or in the case of
the treatment planning system (TPS) the dose calculation method itself.
The PTW cylindrical jig provides an easy and reproducible set-up to calibrate the rectum
probe, bladder probe and MOSkinTM simultaneously against the local standard ionisation
chamber at a distance of 8 cm from the centre of the source. The calibration factors
obtained in the jig are applied to each individual detector reading to obtain a
measurement in units of dose (cGy). Initially, the dose measured in this set-up failed to
agree with the dose calculated to the same points by the TPS when the cylindrical jig was
imaged on the CT and reconstructed in the TPS environment. Monte Carlo simulation
proved this disagreement between measured and calculated doses is caused by the
inability of the TPS to delineate and distinguish the edge of the cylindrical jig from the
surrounding air, hence artificially creating additional scatter around the jig. In order to
achieve improved agreement between the dose measured in the calibration jig and the
TPS, a correction factor for loss of scatter must be applied to all measurements within the
jig.
The calibration factors determined in the cylindrical jig are found to be in good
agreement with those measured in the perspex slab phantom at the same distance of 8 cm
from the source. The advantage of the slab phantom is that it provides full scatter
allowing comparison between the measured dose and TPS calculated dose under the same
scattering conditions. This set-up yields a better agreement for the measured results with
the TPS at the calibration distance of 8 cm. However, when the dosimeters are placed
closer to the source and the calibration factors are applied, the difference between the
measured dose and the TPS increase. While this difference in dose appears large, when
evaluated on the dose fall-off curve as a function of distance from the source in Figure
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5.7, the distance to agreement is less than 2 mm for both the rectum probe and
MOSkinTM.
The final method of calibrating the diode probes and MOSkinTM involves direct
calibration with the TPS. The advantage of this method is that the dosimeters can be
calibrated in terms of dose without the uncertainty associated with the ionisation chamber
volume. Furthermore, the probes can be calibrated close to the source, which is more
representative of where they are used clinically. The limitation of this method is that it
assumes that the rectum diode and MOSkinTM are measuring dose at exactly the same
point as the TPS in the steep dose gradient region. In addition, this method of calibration
for the rectum probe and MOSkinTM is not truly independent of the TPS which was stated
in the first chapter as one of the reasons for a HDR brachytherapy in vivo dosimetry
program.
The outcome of Chapter 5 was to develop a calibration procedure that was accurate,
reproducible and relatively simple to perform on the day of treatment. After evaluating
the different approaches discussed above, calibration of the PTW diode probes and
MOSkinTM with the ionisation chamber in the PTW cylindrical jig provides the most
efficient and reproducible method with an acceptable level of accuracy. The geometry of
the jig establishes a fixed calibration distance of 8 cm and although this distance is not
clinically relevant, the change in dosimeter response when used closer to the source is far
less than the uncertainty associated with calibrating the dosimeters in a large dose
gradient region. In order to get agreement between the dose measured in the jig and that
calculated by the TPS a scatter correction factor must be applied. However, this scatter
correction is not required for determining the calibration factors for each of the
dosimeters in the jig as all the dosimeters are irradiated simultaneously under the same
scattering conditions.

This is demonstrated by the good agreement between the

calibration factors obtained in the jig compared with those measured under full scatter
conditions in the slab phantom. Lastly, the ability to simultaneously calibrate the rectum
probe, bladder probe and MOSkinTM against the ionisation chamber means that this
method is the most time efficient for the calibration of multiple dosimeters.
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Chapter 6:
Discussion and Conclusion
6.1

Summary

As outlined in the first chapter, the goal of this research was to develop and implement an

in vivo dosimetry program for measuring dose to the bladder and rectum during HDR
gynaecological brachytherapy procedures. While there are many different commercial
dosimetry systems available that employ a whole range of different dosimeters, the PTW
Afterloading Semiconductor Probe system and the Centre for Medical Radiation Physics
MOSkinTM Clinical Semiconductor Dosimetry System were the focus of this work.
The preliminary Monte Carlo work performed with the EGSnrc code modelled the
Nucletron microSelectron ‘Classic’

192

Ir high dose rate (HDR) brachytherapy source.

The distribution of dose along the central axis of this source was scored in small voxel
regions within a water phantom. The depth dose data in water was compared with well
known published data for the ‘Classic’ source by Williamson & Li (1995), that of which
is extensively used for dose calculation in many computer based treatment planning
systems (TPS) including the PLATO TPS employed for this work. The agreement with
the published data to within 2% provided confidence in the source model and the
resulting dose and spectra characteristics obtained and later used in the practical
component of this work. Monte Carlo was also utilised to evaluate dose deposited in
small voxels of silicon to imitate the semiconductor material making up the diode probe
detectors and MOSkinTM and provide a base for comparison with the measured data.
Dose scored in silicon was then compared with dose in water and found to be greater at
larger distances from the source due to its higher atomic number Z and the presence of
lower energy scattered photons leading to an increase in photoelectric absorption. The
presence of these low energy photons at depth in a water phantom was confirmed with
analysis of the
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Ir photon spectrum in the FLURZ module of the EGSnrc code. The
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effect of these low energy photons presented a conundrum as to the most appropriate
distance from the source to calibrate the diode probes and MOSkinTM. The trade-off was
that calibrating the dosimeters too close to the source in a steep dose gradient region led
to an increased uncertainty, while at large distances from the source the increased
photoelectric absorption in silicon predicted by the Monte Carlo data would lead to an
over-exaggerated calibration factor, that in turn would ultimately result in an incorrect
measurement of dose closer to the source.

This matter was further investigated in

Chapter 5. One last vital piece of information obtained from the Monte Carlo spectral
data was the use of a formalism to quantitatively calculate the weighted average photon
energy at various depths in water and PMMA. The average photon energy at the 8 cm
calibration depth for the PMMA cylindrical jig was then used to look up the
corresponding value for the mass energy absorption coefficient (µen/ρ). This (µen/ρ) was
then used in Equation 4.1 to calculate the dose measured in the ionisation chamber in
Chapters 4 and 5.
After the completion of the Monte Carlo work, initial measurements were carried out to
examine the properties of the PTW diode probes and MOSkinTM important for dose
measurement around the

192

Ir HDR brachytherapy source.

These included: energy

dependence, angular dependence, linearity, long-term and short-term reproducibility and
temperature dependence.

The PTW rectum and bladder diode probes show similar

characteristics for each of the properties mentioned above and an overall uncertainty of
4.8% and 4.2% was determined for the rectum and bladder probe respectively. The diode
probes show excellent reproducibility and linearity with dose and a relatively small
angular dependence. The major benefit of the PTW rectum probe is that the dose
delivered to the rectum can be measured over a large area with the five diode array
meaning that it is more likely that the rectum tissue receiving the highest dose during
treatment will be identified. The MOSkinTM compares relatively well to the PTW diode
probes for the majority of the properties that were measured. An exception to this is the
large angular dependence displayed by this MOSkinTM design, which led to a greater
overall uncertainty of 8.4% for this device. The unique design of the MOSkinTM has
many desirable characteristics for measuring dose in brachytherapy. Its small physical
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dimensions, minimal packaging and high spatial resolution make it a useful tool for
accurately measuring dose in a high dose gradient region. The advantage of using the
MOSkinTM over the PTW diode array for rectum dose measurement is the ability of the
MOSkinTM to measure at 0.07 mm depth in tissue, or in other words at the surface of the
anterior rectum wall mucosa. This is the region of the rectum that receives the highest
dose and the most likely to develop early or late toxicity if over-dosed. With the aid of a
rectum balloon, the MOSkinTM can be pushed right up against the anterior rectum wall for
measurement during treatment. Due to the physical dimensions of the PTW rectum probe
(7 mm diameter), the dose can only be measured at 3.5 mm from the anterior rectum wall.
In such a steep dose gradient region this would mean a significant difference in measured
dose between the two dosimetry systems.
The final section of work involved developing an appropriate calibration procedure for
accurately determining individual dose calibration factors for the rectum probe, bladder
probe and MOSkinTM. These dose calibration factors were obtained by relating each
dosimeter reading to the dose measured in the local standard ionisation chamber under
the same conditions. The dose measured by the ionisation chamber is traceable back to
the ARPANSA standards laboratory. The PTW cylindrical jig was found to provide the
most accurate and reproducible results for calibrating the dosimeters for use in HDR
brachytherapy. The ability to simultaneously irradiate the PTW diode probes, MOSkinTM
and ionisation chamber meant that calibration factors for the dosimeters can easily be
obtained all at once and in a short period of time. When comparing the dose measured in
the calibration jig set-up with the treatment planning system (TPS), it was found that the
different scattering conditions used by the TPS resulted in a discrepancy between the
measured and TPS calculated dose. This difference was resolved and accounted for
through Monte Carlo simulation of the different scattering conditions and it was found
that a scatter correction of 10.1% at 8 cm was required to account for the TPS inability to
distinguish the boundary of the phantom.
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Both dosimetry systems evaluated in this thesis have shown they are capable of providing
real-time dose information on the organs of risk during HDR brachytherapy procedures
with an acceptable level of accuracy.

The merits of an in vivo dosimetry as an

independent dose calculation to the treatment planning system have been well discussed
and demonstrated throughout this work.

6.2

Discussion of the Limitations and Uncertainties in Dose
Measurement for HDR Brachytherapy

In evaluating the suitability of the PTW diode probes, MOSkinTM and ionisation chamber
for dose measurement and calibration in 192Ir HDR brachytherapy, there were found to be
numerous limitations, approximations and uncertainties that affected the accuracy of
measurement.
The phantom size and scatter conditions were found to have a significant impact on the
dose measured when compared to the same set-up in the treatment planning system (TPS)
dose calculation environment. In the case of the PMMA calibration cylindrical jig of
diameter 20 cm, the lack of scatter material behind each of the dosimeters resulted in a
measured dose that was 8.6% less than that calculated to the same point in the TPS. Poon
& Verhaegen (2009) developed a robust scatter correction formalism to correct for loss of
scatter material at any point within a finite sized phantom. To account for the differences
observed in this work, a simpler but more limited approach was taken by using Monte
Carlo to simulate the dose to the PMMA calibration phantom and compare it to the TPS
by simulating the two cases separately and with identical or equivalent phantom
dimensions to that used in practice. The results of the Monte Carlo simulation found that
10.1% less dose at 8 cm was deposited in the PMMA jig as a result of less scatter than
would be the case in the TPS environment. This value was in good agreement with
literature published for similar sized phantoms and scattering conditions (Tedgren &
Carlsson 2009; and Perez-Calatayud et al. 2004). Applying this correction to the doses
measured in the calibration jig brought the agreement between the measured results and
TPS calculation to within 2%. Therefore, in any situation where the measured dose is
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compared to the dose calculated by the TPS, it is critical that an evaluation of the
scattering conditions are made and where necessary, a correction for loss of scatter is
applied. It has been demonstrated in this work as well as in the literature that Monte
Carlo can be a useful tool for evaluating scattering conditions and how phantom size can
affect the measurement of dose.
The use of the ionisation chamber as the dose standard for calibration of the diode probes
and MOSkinTM provides the benefit of calibrating the dosimeters to be traceable to the
Australian dose standard. However, the use of the ionisation chamber for measuring dose
in the near vicinity of the

192

Ir source introduced large deviations and increased

uncertainty in dose measurement due to the relatively large volume of the air cavity when
compared to the high spatial resolution of diodes and MOSFETs. Tolli & Johansson
(1993b) and Reynaert et al. (1998) have published an extensive list of effects that
influence an ionisation chamber measurement when used for HDR brachytherapy with
192

Ir sources. It is clear from their work that the non-uniformity effect that results from a

non-uniform electron fluence over the chamber cavity has the most significant effect on
the measured reading. For the NE2571 0.6 cc Farmer ionisation chamber, Reynaert
showed the non-uniformity effect to be as large as 35% at 1 cm and 7.7% at 2.5 cm from
the source. Tolli found this effect to be significantly less at extended distances from the
source quoting a value of only 0.2% at 7.7 cm. Relative to the non-uniformity effect,
most of the other influencing effects are small and generally decrease with distance from
the source. The 19% difference observed in Chapter 5 between the dose measured by the
ionisation chamber and the TPS at 2.3 cm from the source is likely to be strongly
influenced by the non-uniformity effect.

Without correctly accounting for the non-

uniformity effect and other influencing effects, the accuracy of ionisation chamber
measurement within 5 cm of the source is very poor. Based on these characteristics of
the ionisation chamber, calibration of the diode probes and MOSkinTM against the
ionisation chamber are best performed at the jig calibration distance of 8 cm.
The concern with the over response of the diode probes and MOSkinTM at 8 cm due to
their silicon components was based on reports in the literature of differing responses of

141

semiconductor dosimeters at low photon energies as well as the Monte Carlo results
presented in Chapter 3. The Monte Carlo results showed that the dose deposited in a
1 mm pure silicon voxel, was higher than the dose deposited in the same sized water
voxel by 25% at 8 cm. When it came to verifying this energy dependence in Chapter 5,
the energy response predicted by Monte Carlo was not observed to be as large in the
measured data.

The MOSkinTM did show some hint of an increased response with

distance from the source, although it is difficult from the data present to fit a curve to the
data and come up with a correction factor solely related to energy dependence. For the
two diode probes, no trend related to energy response was observed. The failure of the
Monte Carlo data to match the results relating to energy dependence indicates that the use
of a 1 mm silicon voxel to approximate the response of the diodes and MOSkinTM was a
rather crude one. It is clear that for a more accurate assessment of energy response the
construction and dimensions of each dosimeter should be properly modelled if Monte
Carlo is to be employed to correct for this effect.
To quantitate the final uncertainty, all known sources of uncertainty must be considered.
In Chapter 4, the inherent characteristics of the rectum probe, bladder probe and
MOSkinTM were found to give a total uncertainty of 4.8%, 4.2% and 8.4% respectively.
This accounted for angular dependence, linearity in detector response, temperature
dependence and reproducibility. For measurement within the PMMA calibration jig at
8 cm from the source, the uncertainty in the obtained calibration factor for the diode
probes would be primarily attributed to the respective inherent uncertainties as positional
uncertainties are less likely to have significant influence at this distance from the source.
In the case of the MOSkinTM the uncertainty might be extended to account for a change in
energy response if an energy correction is applied.

When the rectum probe and

MOSkinTM were used to measure the dose in the slab phantom at 2.3 cm from the source,
differences of 12% and 15% respectively were observed between measurement and the
TPS. These differences corresponded to positioning errors of 1.5 mm and 2 mm in this
steep dose gradient region. From these results it would seem that the uncertainty in
positioning and the positional stability of the dosimeters during in vivo measurement is
much more significant than the uncertainty in the inherent characteristics or any
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observable effects of change in detector response with energy. This is supported by the
clinical data published by Walhausl et al. (2005) for in vivo measurements of 55 cervix
patients where differences of -31% to +90% between the measured and TPS calculated
data were observed and shifts in probe positioning of 2.5 to 3.5 mm reported.
Lastly, it was pointed out earlier that a benefit of the PTW rectum probe with its five
diode array is its ability to measure dose over a greater area of the rectum.

The

calibration of the diode array is based on the method described for calibration in the PTW
cylindrical jig (Section 4.2.4). This method positions the central diode in the array at the
same distance from the source as the centre of the sensitive volume of the ionisation
chamber allowing a reading to dose calibration factor to be determined for the central
diode. For the subsequent diodes in the array, spaced a fixed distance of 15 mm apart,
the MultiCalTM software applies a correction factor for the small difference in distance
from the source compared with the central diode and the ionisation chamber. Calibration
of the five diode array in the cylindrical jig allows a calibration factor relating to dose for
each diode to be obtained in a reproducible set-up environment. If the dose to the
subsequent diodes was to be compared with the TPS a similar or even greater difference
would be expected due to the loss of scatter behind each of the diodes. The use of Monte
Carlo could be used to again quantitate these effects as shown in Chapter 5.
As noted, the characteristaion of the rectum probe was based solely on measurement with
the central diode in the array. While individual characterisation was not performed for
the other diodes in the array, the characteristics are assumed to be similar for all diodes in
the array given they are of the same type and furthermore emanate from the same batch.
Comparison of the PTW rectum and bladder diode probes performed throughout this
work indicate that the two dosimeters display similar characteristics in terms of
reproducibility, linearity, temperature dependence and energy response. In light of these
observations it would seem reasonable to expect similar results for the other diodes in the
array, although further work on characterising the subsequent diodes would confirm these
assumptions. In terms of measurement uncertainty, it is expected that the subsequent
diodes in the array would exhibit similar inherent characteristics to the central diode,
however, given the significance of small positioning errors close to the source it would
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seem that the uncertainty in positioning of the diodes would again have a strong influence
on the accuracy of measurement.

6.3

Future Work

The extent of this work has encompassed the commissioning of the PTW semiconductor
diode probe system and the MOSkinTM Clinical Semiconductor Dosimetry System for

in vivo dosimetry in HDR brachytherapy. Furthermore, it has evaluated the accuracy and
suitability of each system for measuring the dose to the organs at risk (i.e. rectum and
bladder) during gynaecological brachytherapy procedures. This assessment was based
entirely on phantom measurements and the comparison with dose calculated by the
treatment planning system (TPS). The next step is to implement one or both systems
clinically for patient treatment and collect real patient data for evaluation. One hurdle
encountered in this process was gaining approval by sterilisation services at The Canberra
Hospital for clinical use of the dosimetry probes.

The main concern was ensuring that

the sterilisation procedure for the probes complied with hospital regulations and policy.
The original recommended procedure risked damaging the probes and so an alternative
procedure was sought and in recent times agreed to by sterilisation services and medical
physics.
Another concept that has been discussed is the development of standard plans for vaginal
vault brachytherapy. Due to the simplicity of this treatment it has been suggested that an
individual patient CT is not absolutely necessary for this treatment and that the planned
procedure can be performed on a standard template plan for the applicator chosen for
treatment. In this scenario in vivo dosimetry can play a vital role in determining the dose
delivered to the rectum and bladder during treatment as the TPS would no longer be
capable of determining the proximity of the organs at risk to the implant and hence the
dose received by the organ.
The final application of an in vivo dosimetry system will likely extend to HDR prostate
brachytherapy procedures estimated to begin at The Canberra Hospital by the end of
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2010. In the case of introducing any new brachytherapy treatment technique where there
is an absence of local experience, in vivo dosimetry can be a useful tool to build clinician
confidence in the procedure and provide valuable information on expected dose
variations between individual fractions or patient treatments.
Since the completion of this work, the HDR brachytherapy afterloading system has been
upgraded at The Canberra Hospital. As part of the upgrade a new

192

Ir source design

known as the microSelectron V2 is now used. The construction of this source is similar
to the ‘Classic’ source model only with a smaller and thinner encapsulation and a 3.6 mm
active length. The reduced encapsulation will result in less inherent filtration and a small
change in photon spectrum but the overall effect is expected to be small. The TG-43
parameters for this source are incorporated into the TPS for dose calculation. Future
work may extend to modelling of the depth dose data and photon spectrum of the new
source design as well as verifying the calibration factors are consistent with those
measured for the ‘Classic’ source.
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